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Abstract
Both, laymen and experts have always been intrigued by nature’s vast complexity
and variety. Often, these phenomena arise from combination of parts, be they species
in ecosystems, cell types of the human body, or the many proteins of a cell. In this
thesis, I apply bioinformatic means to investigate combinatorial complexity in an
exemplary manner in three diﬀerent aspects: combinations of aliphatic amino acid
side chains, alternative mRNA splicing in fungi, and mutually exclusively spliced
exons in human and mouse.
The ﬁrst part addresses the question of how many theoretically possible aliphatic
amino acid side chains there are, and how many of them are realized in nature.
Structural combinations yield a vast potential for amino acids, yet we ﬁnd that only
a fraction of them are realized. Reasons for this phenomenon are discussed, especially
in the light of restrictions posed by the genetic code. Moreover, strategies for the
need for increased diversity are examined.
In the second part, the extent and prevalence of alternative splicing (AS) in the
fungal kingdom is investigated. To this end, a genome-wide and comparative multi-
species study is conducted. The emphasis lies on normalization of the rates of AS
to allow for a comparability of the species. AS is found to be a common process
in fungi, but with lower frequency compared to plants and animals. Increasing AS
rates are found for more complex fungi. Also, fungal AS is involved in the intricate
process of virulence. The results hint at the contribution of AS to multi-cellular
complexity in fungi.
In the third part, mutually exclusive exon (MXE) splicing is addressed. MXE is an
interdependent type of AS, which has not been so well researched in transcriptome-
wide respect so far. Here, MXEs of mouse and human are detected and characterized.
Rather unexpected patterns are found: the majority of MXEs originate from non-
adjacent exons and frequently appear in clusters. These properties make most of the
found regulatory mechanisms of MXEs of other species unsuitable. New mechanisms
have to be sought for mammals.
Summarizing, several instances in which combinations contribute to biological com-
plexity are investigated in this thesis. It is hypothesized that complexity from com-
binations constitutes a rather universal principle in biology. However, there seems to
be a need to restrict the combinatorial potential. This is highlighted, for example,
in the interdependence of MXEs and the low number of realized amino acids in the
genetic code. Combinatorial complexity and its restriction are discussed with respect
to other biological examples to further substantiate the hypothesis.
Zusammenfassung
Laien und Experten sind seit jeher beeindruckt von der Komplexita¨t und Vielfalt
der Natur. Diese Pha¨nomene entstehen oft durch Kombination von “Teilen”, seien
es Spezies in O¨kosystemen, Zelltypen des menschlichen Ko¨rpers oder die zahlreichen
Proteine einer Zelle. In dieser Dissertation wird kombinatorische Komplexita¨t mittels
bioinformatischer Methoden exemplarisch hinsichtlich dreier Aspekten untersucht:
Kombination aliphatischer Aminosa¨ureseitenketten, alternatives Spleißen in Pilzen
und sich gegenseitig ausschließend gespleißte Exons in Mensch und Maus.
Im ersten Teil wird der Frage nachgegangen, wie viele theoretisch mo¨gliche aliphatis-
che Aminosa¨ureseitenketten es gibt und wie viele davon in der Natur realisiert wer-
den. Kombination in der Seitenkettenstruktur ero¨ﬀnet ein großes Potential fu¨r
Aminosa¨uren. Trotzdem ﬁndet nur ein Bruchteil der mo¨glichen Aminosa¨uren in
der Natur Verwendung. Gru¨nde fu¨r dieses Pha¨nomen werden diskutiert, besonders
hinsichtlich Einschra¨nkungen durch den genetischen Code. Daru¨ber hinaus werden
Strategien der Natur diskutiert, um trotzdem einen erho¨hten Bedarf an Vielfalt zu
decken.
Im zweiten Teil wird das Ausmaß des alternativen Spleißens (AS) im Pilzreich un-
tersucht. Dazu wurde eine genomweite, vergleichende Studie mit mehreren Spezies
durchgefu¨hrt. Ein Schwerpunkt war die Normalisierung der Raten des AS, so dass
Spezies vergleichbar sind. Es wurde herausgefunden, dass AS ein im Pilzreich u¨blicher
Prozess ist, der jedoch im Vergleich zu Pﬂanzen und Tieren seltener auftritt. Kom-
plexere Pilze weisen erho¨hte Raten von AS auf. Außerdem ist AS im komplexen
Prozess der Virulenz mancher Pilze involviert. Die Ergebnisse deuten auf einen
Beitrag von AS zur multizellula¨ren Komplexita¨t in Pilzen hin.
Im dritten Teil werden sich gegenseitig ausschließend gespleißte Exons (MXEs, eng-
lischmutually exclusive exons) untersucht. MXEs sind voneinander abha¨ngige Spleiß-
ereignisse, die bisher wenig transkriptomweit untersucht wurden. Im Rahmen dieser
Arbeit wurden MXEs in Mensch und Maus detektiert und charakterisiert. Dabei
wurden ungewo¨hnliche Muster entdeckt: die meisten MXEs stammen von nicht-
benachbarten Exons und treten ha¨uﬁg in Gruppen auf. Diese Eigenschaften stellen
die Eignung bisher fu¨r andere Tiere bekannter Regulationsmechnismen von MXEs
in Frage. Neue Mechanismen mu¨ssen fu¨r Sa¨ugetiere gefunden werden.
In dieser Arbeit werden mehrere Aspekte untersucht, bei denen Kombination zu biol-
ogischer Komplexita¨t beitra¨gt. Es wird die Hypothese aufgestellt, dass Komplexita¨t
durch Kombination ein eher universelles Prinzip der Natur darstellt. Dennoch scheint
die Beschra¨nkung des kombinatorischen Potentials no¨tig zu sein. Das wird anhand
der gegenseitigen Abha¨ngigkeit von MXEs und der kleinen Zahl tatsa¨chlich verwende-
ter Aminosa¨uren im genetischen Code herausgestellt. Kombinatorische Komplexita¨t
und deren Begrenzung wird an weiteren biologischen Beispielen diskutiert, um die
Hypothese zu bekra¨ftigen.
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1Introduction
1.1 Organismic Complexity
The unraveling of the human genome in around the year 2001 was a surprise for the biosciences1.
While early estimations stated that there are about 100,000 human genes, this number was
constantly reﬁned to lower values during the successive sequencing and analysis of the human
genome. Current estimates claim around 21,000 protein coding genes2. How can such a complex
system as the human be built from only 21,000 genes? And not less intriguing, why do seemingly
less complex species as the worm Caenorhabditis elegans (21,733 genes3) or wheat (> 94,000
genes4) harbor a similar number of genes or even more? Neither the haploid DNA mass (C value
paradox5) nor the number of genes6 correlate with what is perceived as biologic complexity.
There are many concepts of what complexity constitutes and how it is achieved. The main
theme of this thesis is how biological complexity is attained, and which role combinations play.
The central dogma of molecular biology is quite simple, and thus, appealing in the quest for
understanding biology: information is transferred from linear DNA to RNA to proteins and does
not ﬂow back7. The dogma deals with the basic steps of gene expression: DNA transcription
into messenger RNA (mRNA), and mRNA translation into proteins. With a more reﬁned view,
information does not only ﬂow in one direction during gene expression. It rather interferes and
can also be transferred back. RNA and proteins determine which DNA is transcribed and which
mRNA is translated. Further, RNA can be recoded to DNA and incorporated into the genome
sequence by reverse transcription8. Thus, even when neglecting all intricate intermediate steps
of gene expression, life is a highly dynamic system. On the one hand, organisms can proceed
from one developmental state to another, accompanied by great changes in morphology and cell
composition. On the other hand, once being in such a state, healthy organisms reside in an
equilibrium (e.g., maintaining cell identity, metabolite concentrations, gene expression levels),
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which necessitates a dynamical adaptation to their changing environment9,10 and the ability to
regenerate11.
In its pure form, the central dogma stated a one to one relation, a mapping, of genetic in-
formation. Again, in detail it is more complicated. There are bifurcations on many stages of
gene expression. Alternative transcription start sites yield diﬀerent primary transcripts from
one gene12. Alternative splicing and RNA editing give rise to multiple mature isoforms of eu-
karyotic mRNA. Proteins are diversiﬁed by post-translational modiﬁcations8. Hence, counting
the raw number of a species’ genes is not even a rough guide to assess its complexity13. Yet
another loosening of the central dogma is the discovery that a huge part of the transcribed RNA
of eukaryotes is not translated into proteins2. A cellular function has been shown for a remark-
able part of these non-protein-coding RNAs, and thus, puts the theory of the junk-harboring
genome into perspective14. Furthermore, from a more sophisticated view, genetic information
is not only stored in a linear series of symbols. Genomic DNA is organized in a ordered sec-
ondary structure, which taps potential to store additional information15. Additionally, there is
modiﬁcation of histones, the “packaging material” of chromosomes. Variable acetylation and
methylation of histone amino acids are involved in silencing and activation of gene expression16.
In this respect, the notion of epigenetic code is introduced by which further genetic information
can be stored and altered on a short-term basis, as opposed to the slowly evolving sequences of
genomic DNA17.
In order to grasp complex phenomena as species and living matter, a multi-disciplinary ap-
proach with diﬀerent perspectives and methodologies is beneﬁcial. From a computer science
perspective, species can be viewed as information processing entities. Thus, a species’ complex-
ity can be measured by assessing the information it bears. There are two well-known measures
of complexity in computer science: Shannon entropy and Kolmogorov complexity. The ﬁrst one
is understood as the average uncertainty about a sequence of letters, and only involves proba-
bilities of the letters18. Thus, Shannon entropy disregards the sequential order of letters or the
structure of a text. However, Shannon theory was often successfully applied in bioinformatics,
for example, for quantiﬁcation of methylation diﬀerences19, and for automatic detection of a cer-
tain type of cardiac arrhythmia20. Another measure derived from Shannon entropy is mutual
information, which quantiﬁes the information that two objects, as DNA sequences, share21. As
examples, it was used to analyze nucleosome positioning motifs22, and to predict coding regions
in DNA independent of organism-speciﬁc features23. The Kolmogorov complexity or algorithmic
complexity from algorithmic information theory can be interpreted as the length of the shortest
program to describe a sequence of letters24. With respect to Kolmogorov complexity, many
repetitive and low-complexity parts25 make the human genome very compressible. This means,
it could store more information as it actually does. The third measure of complexity I want
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to mention, Trifonov’s linguistic complexity, allows for a closer appreciation of the genome’s
informational structure. It measures the fraction of diﬀerent substrings of a sequence to the
number of possible substrings26. Using it, one can detect that several codes are superimposed
on the genome, e.g. the genetic code and information for nucleosome positioning27. Calcula-
tions of complexity have helped to understand many biological aspects, e.g., to identify disease
genes in genetic association studies28, to quantify splicing disorder in cancer29, and to quantify
nematodes’ morphological aging based on image texture entropy30.
To recapitulate the observation from the beginning, organismic complexity is not a mere question
of how many and which genes an organism has. It rather comprises the complex interplay
and the spatio-temporal combinatorial expression of subsets of the whole gene inventory. In a
similar manner, the beauty and worth of a building can not simply be assessed from the shape
and number of its bricks. A better way to numerically grasp complexity is to account for the
number of macro-level occurrences assembled from the micro-level parts. Thus, many scientists
rather ascribe importance to the number of proteins, tissue types, and developmental stages a
species can produce, than to its gene number13,31. One common observation in nature is the
use of combinations to achieve variety. The central principle leveraged by nature is that a vast
number of diﬀerent compositions can be produced from only a small set of components. This
multiplication is also known in subjects besides biology and called combinatorial explosion32.
In this thesis, biological complexity is investigated from the view point of combinatorial diversity.
As opposed to the approach in systems biology, I rather do not investigate complexity from inter-
relations in biological systems. In the core of this thesis, complexity by combinatorial diversity is
studied on two levels. First, the combinatorics of aliphatic amino acid side chains is investigated.
The theoretical potential of an amino acid inventory is contrasted by the actual realization in
nature. Theories for this discrepancy are discussed, as well as limitations and consequences for
the genetic code. In the second part, two aspects of AS are investigated. The scope and extent
of AS in the fungal kingdom is studied, and potential involvement in virulence and multi-cellular
complexity are investigated and discussed. Finally, human and mouse mutually exclusive splic-
ing events are mined and characterized using bioinformatics methods. Consequences for earlier
proposed regulatory mechanisms are discussed in light of the unexpected ﬁndings.
Throughout this thesis I will use the word “we” when referring to the work involved in producing
the publications embedded in the thesis, as these arose by collaborative work. I will use “I”
when referring to content that solely belongs to this thesis.
3
1. INTRODUCTION
1.2 Amino Acids
Amino acids (AAs) are organic compounds of living cells and constitute the building blocks
of proteins. They are connected in linear fashion by peptide bonds. In aqueous solution as
the cytosol, an AA chain folds to form a protein with spatial structure and physico-chemical
properties. These allow proteins to execute their manifold functions8. The ﬁrst AAs asparagine
and cysteine were discovered in the beginning of the 19th century33,34. Still, it took another
century until proteins were proposed to be composed of AAs35. An AA consists of a central
carbon atom with the following four binding partners: a hydrogen, a carboxyl group (COOH
or COO−), an amino group (NH2 or NH+3 ) and a variable side chain. The side chains have
a high potential variability. Mostly, they consist of branched, unbranched or cyclic carbon
atom structures, often times supplemented with nitrogen, oxygen or sulfur, and saturated with
hydrogens36. The proteinogenic AAs can be partitioned according to their physico-chemical
properties into polar, non-polar, and charged37. Charged and polar AAs are hydrophilic, non-
polar AAs are hydrophobic8. Charged amino acids can further be subdivided into electrical
positively (alkaline) or negatively (acidic) charged8. Hydrophobic AAs are subdivided into
aliphatic and aromatic8. In my ﬁrst publication, aliphatic amino acids are investigated. These
are hydrophobic, contain carbon and hydrogen and have no aromatic rings36. Non-aromatic rings
and multiple bonds are excluded for simpliﬁcation of the calculation, though both would not
conﬂict the deﬁnition of being aliphatic. Furthermore, sulphur, nitrogen and oxygen are allowed
in a less strict deﬁnition of aliphatic AAs, as long as they retain a certain hydrophobicity.
During the formation of the covalent peptide bond, also called condensation reaction, the amino
group of one AA is bound to the carboxyl group of another AA, thereby releasing water. Once a
polypeptide chain of a certain length has formed it can fold to a spatial structure36. During the
thought experiment of Levinthal’s paradox, a cell sequentially samples all possible combinations
of the peptide bond angels to ﬁnd the correct protein structure. Even if these combinations
could be sampled at a time-scale of 10−13 seconds, protein folding would take longer than
the existence of the universe because of the inconceivable number of angel combinations36,38.
In reality, folding is guided by the properties of the contained AAs, which cause attracting
or repelling interactions. In aqueous solutions as the cytosol, hydrophobic AAs strive to be
positioned in the center of a protein, whereas hydrophilic AAs frequently occur on a protein’s
surface36. These forces make sampling of the whole possible fold space unnecessary. Also,
polypeptide chains are thought to form small modules ﬁrst, which are partially correctly folded
transition states. These substructures then funnel the global protein structure formation, so
that folding takes only a few minutes36.
Once proteins attain their natural conformation, they can carry out their cellular function. They
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dynamically bind other molecules to form cell structures or catalyze biochemical reactions8.
There are 20 canonical AAs found in proteins of biological organisms. The set was extended
by the ﬁnding of selenocysteine, the 21st39,40, and pyrrolysine, the 22nd41, non-canonical AAs.
They are not directly represented in the genetic code, but are incorporated by the repurpose
of stop codons in the presence of certain RNA structures42. Besides these proteinogenic AAs,
there are many others that are not incorporated into proteins. They are, for example, secondary
metabolites or precursors of these, e.g., 2-amino butanoic acid for chemical communication
in Globodera rostochiensis 43, or L-norvaline that is an anti-inﬂammatory arginase inhibitor in
human44. Others are metabolic intermediates, as e.g. citrulline and ornithine from the urea cy-
cle36. There is a vast diversity of non-proteinogenic AAs and new ones are discovered frequently,
as, e.g., 2-amino-9,13-dimethyl-heptadecanoic acid secondary metabolite from Streptomyces sp.
101045.
1.3 The Genetic Code
During translation of mRNA into proteins, a ribosome sequentially reads the codons (nucleotide
triplets) of the messenger transcript with the help of transfer RNA (tRNA). The codon sequence
is deciphered into an AA sequence, which will form a new protein. The actual code for translation
is implemented in the tRNA where the anti-codon that matches a speciﬁc mRNA codon is linked
to the corresponding AA. These linkage reactions are conducted by speciﬁc aminoacyl tRNA
synthetases8. During the 1960’s, codons were ﬁrst shown to consist of three nucleotides46, and
subsequently, the code assignments were deciphered by several scientists47. There are 61 codons
coding for 20 AAs. The code is called degenerate since for some AAs more than one codon
exists. However, it is not ambiguous, meaning that no codon can be translated into diﬀerent
AAs. The degeneracy makes the code more stable towards mutations. Consider, e.g., a so-called
fourfold degenerate codon site, where four codons that diﬀer only in one position code for the
same AA. If such a codon mutates at the said position, the encoded AA stays the same. This is
called a synonymous mutation. The methionine codon AUG is also interpreted as translational
start when not positioned within a coding sequence. Furthermore, there are three codons (UAA,
UAG, UGA) interpreted as translational stop8.
There is a multitude of theoretically possible assignments of AAs to codons. However, the
canonical genetic code can be found in all species with only small variations48. An example
are vertebrate mitochondria, where e.g. AGA and AGG are additional stop codons49. The
high similarity of genetic codes hint at a common origin. At the same time, it shows that
such a central part of the gene expression machinery is evolving very slowly, if at all36. An
obvious reason is that a small deviation in the code would have a huge eﬀect on the expression
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of all proteins of an organism. This can hardly be tolerated. It will be discussed later that the
expansion of the AA repertoire is impeded for similar reasons.
1.4 Splicing
Splicing is a process during expression of eukaryotic genes taking place before translation. The
pre-mRNA, resulting from transcription of DNA by RNA-polymerase, contains sequence parts
called exons interspersed with so called introns. The introns are removed during splicing and
the remaining exons are ligated together to form the mature mRNA. Splicing is carried out by
a large complex of ribonucleoproteins in the cell nucleus called the spliceosome. The ﬁve small
nuclear ribonucleoproteins (snRNPs) U1, U2, U4, U5, and U6 assemble in step-wise fashion onto
the intron by recognizing exonic and intronic sequence motifs, and catalyze the splice reactions.
The assembly of the spliceosome needs several other factors, such as U2AF and SF125. In sum,
several hundred molecules take part in coordinating one splicing reaction50, and it is regarded
one of “the most complex macromolecular machine in the cell”51.
The recognition motifs in introns are the 5’ end GU (donor) and the 3’ end AG (acceptor)
dinucleotides, the polypyrimidine upstream of the 3’ end, and the branch site containing an
adenine25. These signals are supposed to contribute around 50% of the information needed
for proper intron recognition52. These motifs have surrounding sequences that harbor further
information, some reach into exonic regions and are conserved. Additionally, there are other cis-
acting (i.e. on the mRNA) splice motifs. These are called intronic and exonic splice enhancers
and silencers, depending on their position and kind of splice regulation25. Increasing evidence
shows that splicing takes part co-transcriptionally at the nascent mRNA parts53. Also, there is
evidence that several spliceosomes can assemble onto one mRNA at the same time54.
Two sequential transesteriﬁcation reactions take place during splicing. In the ﬁrst one, the 5’
end G is attached to the branch site A nucleotide. In the second reaction, the 3’ intron end is
excised and the exons are joined. The branched, loop-shaped intron structure that is formed is
called lariat and degraded afterwards25.
Besides the above described splicing pathway conducted by the so called major spliceosome
there is another very similar pathway. The minor spliceosome excises introns that are ﬂanked
by other consensus dinucleotides. It shares the U5 subunit, but diﬀers in the other ones55.
1.5 Alternative Splicing
Alternative splicing (AS) was ﬁrst discovered in adenoviruses in 197756. Several years later it was
found in cancer cell lines of a self-replicating organism57. AS was considered rather an exception
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for long time. With the rise of new technologies as whole genome sequencing, Sanger sequencing
of ESTs, and microarrays in the 1990s, and even more with the high-throughput sequencing,
the predicted phylogenetic scope and individual extent of AS seems to be ever increasing58,59,60.
During AS, diﬀerent acceptor and/or donor splice sites (SSs) can be chosen by the spliceosome,
and alternative mRNA isoforms are produced. This may lead to alternative protein isoforms,
degradation of spurious transcripts52, or regulatory eﬀects of alternative untranslated regions61.
There are four basic types of AS: cassette exons (CE, or skipped exons), intron retentions (IRs),
alternative 5’ intron ends (A5’SSs) or donor sites, and alternative 3’ intron ends (A3’SSs) or
acceptor sites52. Especially in species with many introns, these basic events can aﬀect a gene’s
transcript in combined fashion and SS choice may be dependent. For example, two exons may
be skipped together62. Furthermore, there are more complex types of AS, for example mutually
exclusive exons (MXEs), in which in its basic form exactly one exon out of two appears in mature
mRNA63.
There are several factors involved in AS. Most important, a SS can be less conserved, mean-
ing that the sequence surrounding the dinucleotide consensus deviates from the one found in
constitutively spliced introns. Thus, the spliceosome can bind less strongly to it. Also, there
has to be a similar strong nearby SS to which the spliceosome can bind alternatively64. Other
factors are exonic and intronic splice enhancers and silencers present in the mRNA25. These
cis-acting factors are bound by trans-acting factors, proteins and ribonucleoproteins, which inﬂu-
ence spliceosome assembly in a concerted manner. One class of trans-factors are serine-arginine
rich (SR) proteins that are generally assumed to enhance splicing65. Another class are hetero-
geneous nuclear ribonucleoproteins (hnRNPs) that are rather splice repressors65. Interestingly,
a splicing factor can have enhancing or repressing eﬀects depending on its distance to the SS
and the context65,66.
The co-transcriptional occurrence of splicing53 opens the potential of regulatory coupling of
both processes. Several ways of coupling have been found. For example, splicing factors can be
recruited to the transcription site with help of the RNA polymerase II67. Also, transcription
factor presence can determine alternative SS usage68. For example, diﬀerent steroid hormones
make hormone receptors recruit diﬀerent promoter coregulators. Evidence was found that these
not only aﬀect transcription, but also inﬂuence the production of AS variants of the target
gene69.
Furthermore, it was demonstrated that transcription speed can inﬂuence AS. A spliceosome has
more time to assemble on an upstream SS when elongation is slow, and the downstream SS will
be chosen less preferentially70. Nucleosomes impede RNA-polymerase II elongation. Thus, in
turn, diﬀerential remodelling of chromatin, that is tightening and loosening of nucleosomes, can
inﬂuence AS outcomes. Post-translational modiﬁcations can set histone marks in chromatin,
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which help recruit splicing factors and spliceosome components, and thus, enhance splicing68.
There were correlations found between absence and presence of speciﬁc histone marks and certain
AS outcomes71. Intriguingly, the so-called Hu proteins, which also aﬀect chromatin structure,
aﬀect splicing in yet another way. They compete for an intronic splice enhancer that is normally
bound by TIA-1/TIAR proteins, and thus, cause skipping of an exon72. In sum, AS is a intricate
process and tightly embedded in other eukaryotic cell activities.
AS takes place in eukaryotes. As a trend, more genes are associated with AS in more highly
developed species, and vertebrates show more AS events than invertebrates73. Mammals are
considered to have the highest AS rates, and human presumably reach the top with 74%74 to
94%75,76 of aﬀected genes. It is generally assumed, that plants show less AS events than animals.
For example, in the monocot rice and dicot Arabidopsis thaliana about 16% and 18% of the TIGR
annotated genes are AS associated, respectively77. The eukaryote kingdom fungi, is less well
investigated with respect to AS. While yeasts show nearly no AS events78,79, other ﬁlamentous
fungi with more complex lifestyles have higher rates, for example, Aspergillus oryzae 8.6%80,
Cryptococcus neoformans 4.2%81, and Coccidioides posadasii with around 1000 AS events79.
AS can have diﬀerent consequences for the encoded proteins. It can inﬂuence intracellular
localization, aﬃnity of binding sites and catalytic activity of enzymes and others65. AS takes
eﬀect on the development and function of whole tissues and organs. For instance, there are many
studies on the role of AS during neuronal development. AS may provide the diversity necessary
for diﬀerentiation into such an intricate structure as the mammalian brain82. Another example
is the sex determination of Drosophila melanogaster, which involves a cascade of splicing factors
(Sxl, Tra). They lead to splicing of the transcription factor Dsx into sex speciﬁc isoforms, which
ultimately determine sex on molecular level via repression and activation of sex speciﬁc genes83.
The third example of AS aﬀecting physiology is about the tropomyosin family that is comprised
of four genes that are alternatively spliced into 15-20 isoforms with speciﬁc properties. As
example, exon 6A and 6B are mutually exclusive and are expressed speciﬁcally in either smooth
or skeletal muscle cells84. Interestingly, it is not always the presence of one or the other splice
variant that determines the cellular eﬀect, but sometimes the exact ratio of the variants, as can
be seen for isoforms of the murine membrane protein Prominin-185.
There is an ongoing debate what fraction of the known AS events are functionally relevant
for cells. Most of the A5’SSs and A3’SSs are only three nucleotides long, and thus, are called
tandem acceptors and donors86. They were proposed to be ’noise’ of the unreliably binding
spliceosome87. However, other scientists speculate that these events may ’ﬁne-tune’ the pro-
teome88. A more recent study shows, that tandem acceptors are regulated in tissue-speciﬁc
way, and thus, likely have a function89.
Only 66% of alternatively skipped exons conserved between human and mouse keep the reading
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frame, as their length is a multiple of three, the codon length52. Frame-shifting AS events
unlikely produces sensible coding sequences, because it is very unlikely to have two overlapping
protein-coding reading frames. On top, when considering frame-shifted sequences as random
sequences, the chance of stop codons is very high (three out of 64 possible codons). Hence, the
resulting proteins are truncated because they contain premature termination codons (PTCs).
In order to prevent these spurious transcripts to cause harm to the cell, many species have the
nonsense-mediatad mRNA decay (NMD) pathway to degrade them. Research shows that NMD
is a widely spread mechanism in the three eukaryotic crown groups90,91,92. While it is generally
accepted that NMD is for removal of aberrant transcripts93, evidence is accumulating that NMD
and AS may act in conjunction to control gene expression94. Simply put, gene expression can be
switched oﬀ by splicing the mRNA into an alternative isoform that has a PTC, and thus, gets
degraded via NMD. Hence, splice factors can ontrol the fate of mRNA. As splice factor expression
and recruitment are regulated by the cell, intricate gene expression patterns can be produced
via this pathway. Thus, coupling of AS and NMD can be understood as another layer of gene
expression control, taking place between transcription and translation52, allowing for additional
regulatory complexity. However, it is currently not known to which extent frame-shifting AS
events are actually used for gene expression regulation via this coupling.
AS is part of the explanation for the vast amount of more than one million diﬀerent human
proteins that are expressed from only about 21,000 genes. The potential of AS lies in joining
the existing gene material to new compositions, thereby enhancing combinatorial complexity.
The potential is corroborated by the fact that 94% of the human genes are multi-exonic, and
the average human gene has 7.8 introns95. Indeed, it was proposed that multiexon genes are
aﬀected by at least seven AS events on average76.
1.6 The Fungal Kingdom
Fungi are one of the ﬁve kingdoms1 of the eukaryotes, next to Protozoa, Animalia, Plantae
and Chromista100. Fungi form a phylogenetic sister group to the multicellular animals, from
which they have diverged around one billion years ago101. Fungi occupy many ecological niches
and spread across diverse habitats around the globe. Their appearance reaches from being
single cellular micro-organisms of a few micrometers in diameter (e.g. the yeast Saccharomyces
cerevisiae) to mushrooms having ﬁlaments that reach an extent of hundreds of hectares102,103.
It is estimated that around 5.1 million fungal species exist on earth based on high-throughput
sequencing experiments104. Fungi take a crucial role in the global carbon cycle. They decompose
1Note, there are other classiﬁcations that divide eukaryotes into, e.g., four96 or six97,98 groups. The correct
division is under debate and no single consensus has been found99.
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extant material of bacteria, plants and animals. The resulting compounds are taken into the
cycle again102.
Fungi live on wood, in soil, water, on plant and animal debris, on dead organisms or make
diverse forms of symbioses with other species. Many fungi spread their spores via air. They
are not capable of doing photosynthesis, and hence, are heterotrophic. Fungi do not ingest
food as animals do, but get nutrients only by absorption. They are usually saprotrophs, i.e.,
they digest organic material extracellularly and import the resulting compounds. Their diverse
appearances and versatility have brought about some bizarre behavior, as e.g., a fungus that
traps roundworms Arthrobotrys oligospora 102.
The fungal kingdom can be subclassiﬁed into six groups (phyla): Chytridiomycota, Neocalli-
mastigomycota, Blastocladiomycota, Glomeromycota, Ascomycota, and Basidiomycota 105. The
Microsporidia, which Hibbett et al.105 still classify as fungi, are now considered a sister group
of fungi106. Ascomycota and Basidiomycota form the subkingdom Dikarya, and are often called
higher fungi. Further, there are ﬁve subphyla incertae sedis with uncertain taxonomic place-
ment105,107. Rhizopus oryzae belongs to one such taxon, the Mucoromycotina 105.
Fungi mostly posses hyphae (ﬁlaments) or are closely related to hyphal species. Their cell
walls harbor chitin but no cellulose during most part of their life108. Most fungi are known to
have a sexual phase. During this, they produce spores, which are useful for a fungi’s classiﬁ-
cation because they have distinctive shapes. Ascomycota (more informally Ascomycetes) and
Basidiomycota (informally Basidiomycetes) have cross-walls (septa) that divide the hyphae into
compartments. Basidiomycetes account for many of the well known mushrooms, toadstools,
rusts and smuts. Some higher fungi lack a sexual phase but build asexual spores. They are
called mitosporic (from mitoses) fungi102.
Besides the predominant hyphal fungi there are yeasts, which are usually unicellular. These
are, for example, the baker’s or brewer’s yeast Saccharomyces cerevisiae and the ﬁssion yeast
Schizosaccharomyces pombe. Some of the normally multicellular growing fungi are capable to
switch to unicellular growth and vice versa. This is called dimorphism or dimorphic switching
and is inﬂuenced by the environmental conditions of a fungus102. The dimorphic switch allows
pathogenic fungi to adapt to the micro environment during invasion of the host tissue. Thus,
pathogens can make use of changing nutrients supply and cope with the host defense109.
One wide-spread form of fungal symbiosis is mutualism where both species beneﬁt from their
alliance. Intriguingly, more than 90% of plants have fungi associated with their roots (mycor-
rhizae). They help the plants to take up nutrients from the soil. Another interesting form of
mutualism are lichens, symbioses of fungi with algae or cyanobacteria. They live in humid areas
afar from human civilization and cover 8% of the earth’s surface102.
Fungal pathogens are responsible for parasitic symbioses causing great negative eﬀects on mankind.
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On the one hand, there are plant pathogens causing billions of crop loss in the USA alone110.
On the other hand, there are human pathogens responsible for diverse, wide-spread diseases,
some of which result in high mortality rates111,112. There are two types of human pathogenic
fungi. The true pathogens invade healthy humans, e.g. Coccidioides immitis 102. Then there
are opportunistic pathogens, which almost exclusively infect immunocompromised individuals.
The immune system is hampered and the already present opportunist has a chance to attack
the body113. Infections have several stages of severity reaching from superﬁcial to systemic.
In the latter case, multiple body parts are infected, treatment is nearly impossible, and the
mortality rate is extremely high111,112. There are several virulence factors necessary for an in-
fection. Hyphae growth facilitates penetration of host tissue. Typically, an arsenal of secreted
lytic enzymes enables the pathogen to advance by destroying host cells. Another factor is the
ability to grow in the unusual host environment. Fungal pathogens must cope with the high
body temperature and a diﬀerent pH. The presence of minerals, as iron and copper, in diﬀerent
organs are often times virulence factors too, making the pathogens more aggressive as they use
these minerals. ’Successful’ pathogens have developed diﬀerent strategies to ward oﬀ attacks of
the immune system114,115. Other fungi make parasitic symbioses with other animals, as insects,
Amphibia and ﬁsh. Plant diseases as rust, smut and mildew are caused by plant pathogens102.
Besides the mentioned threads, there is a wide range of beneﬁts from fungi. For centuries,
fungi have been used for human nutrition in form of edible mushrooms, yeasts for bakery and
brewing, and fungi for diverse soft cheeses and drinks. Other fungi are used to produce antibiotics
(e.g. penicillin), immunosuppressive drugs, steroids102, citric acids and numerous commercial
enzymes116. Next to bacteria, yeasts are used to produce so-called ’biofuels’ from lignocellulosic
biomass for alternative energy supply117. For decades, fungi as S. cerevisae and N. crassa have
been scientiﬁc study objects, which enabled advances in genetics and molecular biology102. The
thousands not yet investigated fungi carry a vast potential for discovery of natural products as
secondary metabolites. There are many scientists and whole institutes, as the Jena Hans-Kno¨ll
Institute, dedicated to the quest for new drugs.
The choice of fungi as object for AS analysis had three reasons. First, the understanding of
fungi’s lifestyles and cellular functions is medically highly relevant. Second, one of the main
research ﬁelds of the Leibniz Institute for Natural Product Research and Infection Biology -
Hans-Kno¨ll-Institute (HKI) Jena - is the infection biology of fungi. And third, the Jena Microbial
Resource Collection (JMRC) localized at the HKI has great expertise in researching fungi. These
circumstances led to the fact that Jena oﬀered a great network of scientiﬁc collaboration partners
to study fungi.
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2.1 Combinatorics of aliphatic amino acids
In the publication of Gru¨tzmann et al. 2011118 we calculate the number of theoretically possible
aliphatic amino acids as a function of the number of carbon atoms in the side chain. We discuss
which of the theoretically possible structures actually occur in living organisms. Our results
reﬂect the general phenomenon in biology that usually a small number of molecules are used as
building blocks to assemble a huge number of diﬀerent macro-molecules, thereby giving rise to
biological complexity.
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Abstract This study combines biology and mathematics,
showing that a relatively simple question from molecular
biology can lead to complicated mathematics. The question
is how to calculate the number of theoretically possible
aliphatic amino acids as a function of the number of carbon
atoms in the side chain. The presented calculation is based
on earlier results from theoretical chemistry concerning
alkyl compounds. Mathematical properties of this number
series are highlighted. We discuss which of the theoretically
possible structures really occur in living organisms, such as
leucine and isoleucine with a chain length of four. This is
done both for a strict definition of aliphatic amino acids
only involving carbon and hydrogen atoms in their side
chain and for a less strict definition allowing sulphur,
nitrogen and oxygen atoms. While the main focus is on
proteinogenic amino acids, we also give several examples
of non-proteinogenic aliphatic amino acids, playing a role,
for instance, in signalling. The results are in agreement with
a general phenomenon found in biology: Usually, only a
small number of molecules are chosen as building blocks to
assemble an inconceivable number of different macro-
molecules as proteins. Thus, natural biological complexity
arises from the multifarious combination of building
blocks.
Keywords Aliphatic amino acids . Aliphatic side chain .
Amino acid signalling . Enumeration of isomers . Pólya’s
enumeration theorem . Ternary tree graphs
Introduction
Obviously, life on earth forms complex structures. On the
other hand, on many scales of living systems, only
relatively few building blocks are used. For example, out
of more than 100 chemical elements, only six are mainly
used: carbon, hydrogen, oxygen, nitrogen, sulphur and
phosphorus (Lodish et al. 2000). Only four nucleobases
appear in DNA: guanine, adenine, cytosine and thymine.
Proteins are built from a limited set of amino acids (Alberts
et al. 2007). Currently, 22 different amino acids with
specific codons in the genetic code are known, with
selenocysteine (Lee et al. 1989; Leinfelder et al. 1989)
and pyrrolysine (Srinivasan et al. 2002) being the 21st and
22nd. In addition, there are a number of amino acids arising
from post-translational modification, such as hydroxypro-
line (Colley and Baenziger 1987) and hydroxylysine
(Miller and Robertson 1973; Kannicht 2002). Moreover,
there are a number of non-proteinogenic amino acids such
as citrulline and ornithine, which are metabolites in the urea
cycle (Berg et al. 2002). A nice overview of proteinogenic
and non-proteinogenic amino acids (about 50 in total) was
given by Karas (1954). He provided a systematisation in
terms of their side chain length and functional groups.
The number of encoded amino acids is relatively small
in view of the enormous number of possible chemical
structures of side chains. Analysing the complete combina-
torics under consideration of all the five chemical elements
mentioned above, single and double bonds, branched and
ring-shaped structures etc. is next to impossible. In contrast,
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if we restrict the analysis to a certain class of amino acids
such as the aliphatic amino acids, combinatorial analysis is
feasible and still provides insightful and non-trivial results.
Therefore, we use, in this manuscript, a number of
restrictions specified below.
In the “Mathematical approach” section, we show how to
calculate the number of theoretically possible aliphatic amino
acids, whose side chains are composed of n=1, 2, 3, …
carbon atoms. Similar combinatorics studies have been
performed for alcohols (Henze and Blair 1931) and hydro-
carbons (Balaban et al. 1988), but not yet for amino acids.
More specifically, we consider α-amino acids. Their central
branching point is the Cα atom, to which an H atom, the
amino group and the carboxyl group are bound (while in β-
amino acids, the amino group is bound to the Cβ atom). The
fourth binding partner is the side chain. In aliphatic amino
acids, the side chain is a hydrocarbon.
Moreover, we use the restrictions that each carbon in the
side chain is saturated with H atoms and that the side chain
only contains single bonds and no rings. While the term
‘aliphatic’ would not exclude saturated rings, this would
render the calculation much more complicated. Chirality is
disregarded, that is, different stereoisomers are not counted
separately.
In the “Biochemical implications” section, we examine
how many of the theoretically possible aliphatic amino
acids actually occur in proteins or with other biological
functions. Finally, in the “Discussion” section, we consider
some evolutionary aspects.
Mathematical approach
The side chains defined above can be considered mathema-
tically as a graph, where carbon atoms (except Cα and C in the
carboxyl group) are nodes and the bonds between them are
edges of the graph. More precisely, it is a tree graph, since we
exclude cycles. The Cβ atom, which is the first C atom of the
side chain, can be viewed as the root of the tree. Every C
atom can bind a maximum of four other C atoms. When
considering this tree as a directed graph, each node can have
at most three child nodes because one bond is the edge to the
father node. That is, the maximum out-degree is three. So the
task is to find the number of all trees with n nodes and out-
degree less than, or equal to, three. For the case of
hydrocarbons, this task has been approached already in the
end of the nineteenth century by Cayley (1874), up to n=6
carbon atoms. A recursion formula has been found by Henze
and Blair in 1931, and the numbers were given up to n=20.
Now, we recapitulate how to calculate the number of
trees with the above-mentioned properties and apply them
to the theoretically possible aliphatic amino acids. In each
case, we refer to the ‘biological realisations’.
Let xn be the number in question. We will advance in a
recursive manner for increasing n. We start with x0=1,
which is realised in the amino acid glycine. Assume we
know all xi for i=0 to k. To determine xk+1, we start from
the Cβ atom and attach exactly three side chains to it, each
of which can use a certain number of carbon atoms such
that the sum of these numbers equals k (Fig. 1).
Because the number of possible structures results from
multiplication of the numbers of possibilities for the
subgraphs, each xk+1 can be calculated by multiplying
terms of the series with smaller indices. In the following
calculation, it is convenient to sort the side chains by the
number of atoms in increasing manner.
x1 ¼ x0x0x0 ¼ 1ðalanineÞ ð1Þ
x2 ¼ x1x0x0
¼ 1 not realized by a proteinogenic amino acidð Þ ð2Þ
x3 ¼ x2x0x0 þ x1x1x0
¼ 2 one of which is realized by valineð Þ ð3Þ
In the following, the tuple (i, j,l) represents three attached
subgraphs with i, j and l C atoms, respectively. For n=4, the
combinations (3,0,0), (2,1,0) and (1,1,1) yield 2, 1 and 1
possible subgraphs, respectively. Their sum is x4 ¼ 4. The
biological realisations will be discussed in the following
section. For n=5, the combinations (4,0,0), (3,1,0), (2,2,0)
and (2,1,1) yield 4, 2, 1 and 1 possible subgraphs,
respectively. Their sum is x5 ¼ 8. Analogously, we obtain
x6 ¼ 17. Notably, Cayley (1874) wrongly calculated this
number to be 13.
In the calculation of x7, the combination (3,3,0)
occurs. For this, one has to account for symmetry, since
attaching a branched chain with k=3 to one side and an
unbranched chain with k=3 to the other side amounts to
the same as doing this the other way round (Fig. 2). We
can think of pulling two balls from an urn containing
two balls (corresponding to branched and unbranched
chains), with placing balls back. Thus, the selected
items are not necessarily distinct. In mathematical
Fig. 1 Schematic picture of the
structure of aliphatic amino
acids. Three dots stand for a tree
subgraph, with i, j and l nodes,
where i+j+l=k. If one of these
indices equals zero, there is only
an H atom attached
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terms, this is a combination with repetition. The number
i s g iven by
2þ 2 1
2
 
¼ 3 ðrather than 2  2 ¼ 4Þ
Together with the other combinations, we obtain
x7 ¼ 39. The next term is x8 ¼ 89, where we again took
into account that the combination (3,3,1) yields
3
2
 
¼ 3.
The following recurrence formula with initialisation
x
0
=1 can be used (Pólya 1937).
xn ¼ 16
X
iþjþk¼n1
xixjxk þ 3
X
iþ2j¼n1
xixj þ 2
X
3i¼n1
xi
 !
ð4Þ
where the sums are taken over all i; j; k  0, and we set
x0=1.
An illustration of this formula is given in Fig. 2. The sketches
of two alternative proofs are given in the Appendix. No closed
formula is known for the exact calculation of the series.
The sequence x1, x2,… increases very rapidly: 1, 1, 1, 2,
4, 8, 17, 39, 89, 211, 507, … In fact, it increases more
rapidly than 2n−2, as can be shown as follows. From x5 on,
the recursion is
xn ¼ xn1x0x0 þ xn2x1x0 þ xn3x2x0 þ xn3x1x1 þ . . . ð5Þ
Thus, xnxn1þ xn2þ 2xn3. By induction, we conclude
xn  2n3 þ 2n4 þ 2  2n5 ¼ 2n3 þ 2n4 þ 2n4
¼ 2n3 þ 2n3 ¼ 2n2 ð6Þ
Below, we will give the exact basis for the asymptotic
exponential growth. It is easy to see already here that the
series grows more slowly than 4n: At each carbon atom,
there are four possibilities of continuation, attaching 0, 1, 2
or 3 carbon atoms. Thus, the basis lies between 2 and 4. In
1937, Pólya showed that the exponential base of growth is
in the interval (2.77, 2.86). In 1948, Otter calculated the
exact asymptotic behaviour of xn to be
xn  0:5178760  2:81546n  n3=2 ð7Þ
This result builds upon a generating function TðzÞ ¼
x0z0 þ x1z1 þ x2z2 þ . . . (see Appendix) and on an analysis
of its asymptotic behaviour. We omit the sophisticated
mathematical details. For n=1, the approximation gives a
value of 1.458 with the correct value being 1. For very low
n values, the approximation formula is not needed, though,
because the exact values can be calculated easily. It is
remarkable that from n=3 on, estimates from Eq. 7 are very
reliable (Fig. 3). For n=3 and n=19, for example, the
approximation yields 2.22 and 2,175,376.00, respectively.
Rounding the former value to an integer gives the correct
value. The relative deviation of the latter value to the exact
number of 2,156,010 is about 1%.
Biochemical implications
As briefly mentioned in the “Mathematical approach”
section, some of the possible aliphatic amino acids do
occur in proteins while others do not. Moreover, some non-
proteinogenic amino acids fulfil other biological functions
such as molecular signalling. Based on a comprehensive
literature search, Table 1 summarises the role of aliphatic
amino acids in living organisms.
Strictly speaking, side chains of length three in proteino-
genic amino acids are only realised by valine. In the broader
sense, proline also belongs to that group since it has three C
atoms in its side chain. These C atoms form a five-ring with
the Cα atom and the N atom of the imino group.
It is interesting to plot the series xn/(n+2) (Fig. 4). This
gives the number of possible variants of aliphatic amino
acids per carbon ‘invested’ by the organism. The ‘invest-
a b c
Fig. 2 Scheme illustrating the recursive calculation in Eq. 4. Sub-
figures a, b and c essentially correspond to the three terms in Eq. 4.
Grey (white) triangles correspond to subtrees that are (not) identical.
Note the role of symmetry, in that the exchange of grey subtrees does
not lead to a different structure
Fig. 3 Diagram showing a comparison of the series xn (blue/dark grey
bars) and its approximation (red/light grey bars) given in Eq. 7 for n=
1, 2, 3, …, 9. Note that for n=0 the approximation is not applicable
since in this case the power term n−3/2 is not defined
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ment’ is represented by n+2 because the Cα atom and the
carbon in the carboxyl group must also be taken into
account. It can be seen that the series has a minimum at n=
2. Thus, it may be speculated that x2 is not realised because
it provides only one possible side chain, as in the case of x0
and x1, but implies higher carbon ‘costs’. A major reason
for the observation that side chains longer than n=4 are not
used in proteins is probably the fact that their solubility in
aqueous medium decreases with increasing length (see also
the “Discussion” section).
There are no unbranched side chains of two, three or
four C atoms in proteinogenic amino acids. However, when
sulphur and selenium atoms are allowed besides carbons,
side chains of length two and three can be found in
cysteine, selenocysteine and methionine (Table 1 and
Fig. 5). Indeed, methionine, which has a lower dipole
moment than cysteine, is often classified as an aliphatic
amino acid. When two cysteines form as disulphide bond,
the resulting chain (sometimes called cystine) can be
considered as aliphatic with n=4. The two dipole moments
Table 1 Biological functions of aliphatic amino acids (AAs)
Length n 
of side 
chain 
No. of 
possible 
struc-
tures 
No. of 
known 
proteino-
genic AAs 
Amino acids Chemical formula Structure of side chain Occurrence
Proteinogenic AAs 
if definition is less 
strict 
0 1 1 Gly CO2—CH2-NH3+ Proteins
1 1 1 Ala CO2—C2H4-NH3+ Proteins
2 1 0 2-amino 
butanoic 
acid 
CO2—C3H6-NH3+ Chemical 
communication in 
Globodera 
rostochiensis (Riga 
et al. 1997) 
Cys, Sec, Ser 
3 2 1 Val 
L-norvaline 
CO2—C4H8-NH3+ Proteins  
Anti-inflammatory 
arginase inhibitor 
(human) (Ming et 
al. 2009)
Pro, Thr 
4 4 2 Leu 
Ile 
L-norleucine 
CO2—C5H10-NH3+ Proteins 
Proteins 
Metabolite in 
orchidaceous 
plants (Kikuchi et 
Met, Cystine 
5 8 0 4-methyl L-
norleucine 
CO2—C6H12-NH3+ Seed of Aesculus
californica (horse
chestnut) (Fowden
and Smith 1968)     
Lys 
6 17 0 - CO2—C7H14-NH3+
7 39 0 - CO2—C8H16-NH3+ Arg 
... 
17 321,198 0 2-amino-9,13-
dimethyl-
heptadecanoic
acid
CO2—C18H36-NH3+ secondary
metabolite from
Streptomyces sp.
1010 (Ivanova et
al. 2001)     
al. 1981) 
3-methyl
valine
Not yet found 
Proteinogenic AAs are given in the three-letter code (Sec selenocysteine). Other atoms than C and H are allowed for the less strict definition of
AAs (last column)
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of the cysteines cancel each other, so that cystine is
hydrophobic (Taylor 1986).
In the broader sense, lysine could be considered as an
aliphatic amino acid with five nodes in its side chain. The
last node consists of nitrogen. Although lysine is regarded
as a polar amino acid, it is quite hydrophobic in the central
region due to the methylene groups. With such an extension
to heteroatoms, also serine and threonine (involving oxygen
atoms in the side chains) can be included (Fig. 5). If we
relax the definition even more, we could include arginine,
having three nitrogen atoms and one double bond in the
side chain. It corresponds to a graph with seven nodes. In
addition to the proteinogenic amino acids given in the
column of Table 1, there are non-proteinogenic amino acids
with a less strict definition of aliphatic properties. Examples
are homocysteine (n=3) and ornithine (n=4).
Both lysine and arginine can be methylated at their side
chain nitrogen atoms when incorporated in proteins, for
example, histones (Kim et al. 2009). Other post-
translational histone modifications include acetylation,
ubiquitination and sumoylation (with SUMO proteins,
Small Ubiquitin-like Modifier) of lysines, and phosphory-
lation of serine and threonine (Kim et al. 2009). These
mechanisms increase the number of possibilities realised in
nature even more.
Discussion
Here, we have analysed the combinatorics of aliphatic
amino acids. Although the rules of molecular structure of
these amino acids are relatively simple, it is a non-trivial
task to compute the number of different isomers as a
function of the number of carbon atoms. Under several
restrictions such as exclusion of rings and double bonds,
that function can be expressed as a series of numbers,
which shows asymptotic exponential growth. This series
has several other applications in theoretical chemistry, for
example the number of isomeric primary alcohols ignoring
stereoisomers (Henze and Blair 1931), the number of rooted
ternary trees (Otter 1948; Balaban et al. 1988), that is,
rooted trees with exactly three children at every node.
For n=0, 1 or 2, there is one possible structure each. The
former two cases really occur in proteins: glycine and
alanine (Table 1). The amino acid with n=2, 2-amino
butanoic acid, is not proteinogenic but plays a role in
signalling. With increasing n, a smaller and smaller fraction
of the theoretical possibilities are realised. Thus, in the
course of evolution, only a small number of all possible
amino acids have been chosen as building blocks to
assemble an inconceivable number of different proteins.
So, natural biological complexity is made up of a small
Fig. 4 Diagram showing quantity xn/(n+2) as a function of the
number of carbon atoms in the side chain, n. That quantity can be
regarded as the number of possible variants of aliphatic amino acids
per ‘invested’ carbon by the organism. The n+2 atoms include n
carbons for the side chain, the Cα atom and the carbon in the carboxyl
group. Note the minimum at n=2 (interpretation see text)
Fig. 5 Graph-theoretical repre-
sentation of the side chains of
‘aliphatic’ amino acids with
heteroatoms. Note that, in pro-
line, the nitrogen from the
backbone amino group and the
Cα atom are not counted as part
of the side chain. In arginine, the
double bond to the N branching
from the main side chain is
represented by a single edge
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tractable alphabet. Actual multiplicity arises from combi-
nation. This principle can also be observed for other
biological macromolecules such as DNA and RNA (Alberts
et al. 2007). The use of a controllable amount of units for
the building of proteins favours a controllable genetic code
for the transmission of information. Multiplicity by combi-
nation can also be observed in the case of glycans and
glycolipids (Gabius 2009).
For proteins, this observation may have several practical
reasons. Aliphatic amino acids with long side chains are
practically insoluble in the aqueous environment of the
cytosol. This would lead to the precipitation of either the
free amino acid upon its synthesis or the peptides or
proteins containing it. Secondly, large amino acids would
require longer and, thus, slower biosynthesis pathways and
their synthesis would be more costly (Seligmann 2003).
Moreover, the atoms of longer side chains with a high
degree of branching would sterically hinder each other. At
the level of protein structures, bulky side chains are
cumbersome for folding and functioning of macromole-
cules. Binding pockets and catalytic sites might be blocked
and conformation changes could be impossible. These are
crucial evolutionary drawbacks of unflexible proteins.
Beside the argumentation for structural and functional
optimisation, another reason for nature using exactly
those amino acids mentioned above is illustrated by the
notion of ‘frozen accident’ (Crick 1968). According to
this hypothesis, the set of present amino acids is relatively
ancient. The set could not be optimised further because it
is used by higher-level mechanisms such as the transcription–
translation machinery and the genetic code that strongly rely
on them and cannot tolerate any change in, or addition
of, building blocks. However, there are exceptions to
this rule. Selenocysteine and pyrrolysine were probably
recruited later, and former stop codons are now used
alternatively for these amino acids (Leinfelder et al.
1989; Srinivasan et al. 2002).
Miller and Urey (1959) showed in their famous experi-
ment that in a simulated atmosphere of pre-biotic earth only
consisting of water, methane (CH4), ammonia (NH3) and
hydrogen (H2), several amino acids can be produced
spontaneously. These include the aliphatic amino acids
glycine, β-alanine (in which the amino group is bound to
the Cβ atom), alanine, sarcosine (glycine with an additional
methyl group bound to the amino group), n-methylalanine
(alanine methylated at the amino group), α-amino-n-butyric
acid and α-aminoisobutyric acid. The latter does not belong
to the class of amino acids considered here because it
involves two methyl groups linked to the Cα atom. In
contrast, α-amino-n-butyric acid represents the x2=1
aliphatic amino acid with two carbons in the side chain.
Thus, it is not disfavoured by chemical reasons; there
must have been additional evolutionary pressure against
its usage in proteins. We have here suggested that the
absence of isomers of the side chain and, thus, the lack
of variability in spite of the relatively high investment
of four carbons may be a reason for not using it in
proteins.
The present analysis shows that biochemistry and
mathematics can nicely be combined. Starting from a
relatively simple question, rather complex mathematics
can be done. This combination may help students to put a
classification into the set of amino acids. This may also
facilitate to learn their structures, which is rather uninspir-
ing otherwise.
Throughout, we have neglected chirality, that is, stereo-
isomers have been considered equivalent. Of course,
chirality is important for biological activity. Among the
proteinogenic amino acids, isoleucine and threonine are
chiral in their side chains. The stereoisomers, alloisoleucine
and allothreonine, are practically not used in proteins.
When this effect is taken into account, the series of
numbers of possible structures increases even more rapidly
starting from n=4 on, with x4=5 and x5=11 rather than 4
and 8, respectively.
It is worth mentioning that nature has brought about
further structures by replacing the hydrogen atom that is
bound to the Cα atom by an alkyl chain. For example, in 2-
ethyl-norvaline, an unbranched propyl group and an ethyl
group are bound to the Cα atom. This amino acid is part of
a cytotoxic peptide and antibiotic of the fungus Tolypocla-
dium geodes (Tsantrizos et al. 1996). Further amino acids
Fig. 6 Illustration of the re-
placement of rooted trees with
n nodes and at most three
children at every node (a) by
rooted trees with exactly three
children at every node, and n
internal (non-leaf) vertices (b).
The nodes of the original tree
(circles) become internal nodes
of the new tree by adding new
leaves (squares)
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with deviating basic structures such as sarcosine (N-
methylglycine) were listed by Karas (1954).
The huge diversity of proteins arises in at least two ways: in
addition to the versatile combination of the building blocks,
their modification after incorporation into the protein plays an
important role, as is realised, for example, by post-translational
modification of amino acids. From an evolutionary point
of view, one may argue that in early evolution, a smaller
set of elementary units was sufficient. Later, with increasing
complexity of the organisms, evolution has not only com-
bined these elements but also ‘tinkered’ with them by
multitudinous modifications.
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Appendix
There are (at least) two ways to prove the recurrence formula
(4). The “elegant” way uses Pólya’s Enumeration Theorem
(Pólya 1937) (also known as Redfield-Pólya’s Theorem) to
do so: Here, we first notice that instead of counting rooted
trees with n nodes and at most three children at every node,
we can also count rooted trees with exactly three children at
every node, and n internal (non-leaf) vertices. To see this, we
simply complete a rooted tree by attaching up to three leaves
to every node of the original tree, so that all vertices except
the new leaves have degree three (Fig. 6). Such trees are
called rooted ternary trees. Then, we note that the symmetry
between such trees is due to arbitrarily sorting the children of
any node. The mathematical representation of this fact is the
symmetric group S3. One proceeds by computing the cycle
index of S3, which is
ZðS3Þ ¼ 16 a1
3 þ 3a1a2 þ 2a3
 
:
It is helpful to consider the generating function TðzÞ for
the number of rooted ternary trees, which is defined as
TðzÞ ¼ x0z0 þ x1z1 þ x2z2 þ . . ., where xn are exactly the
numbers introduced above. Pólya’s Enumeration Theorem
(Pólya 1937) then tells us that this function fulfils the
functional equation
TðzÞ ¼ 1þ 1
6
z TðzÞ3 þ 3TðzÞT z2 þ 2T z3 h i ð8Þ
With the functional equation, we can now calculate the
coefficient of any power zn in the generating function: for
example, regarding T z3ð Þ, the three coefficients must add
up to n−1. Doing so, we directly reach Eq. 4. We omit all
further detail and refer the reader to any textbook about
generating functions (e.g. Wilf 1994).
Now, we show a direct way to prove Eq. 4. Before doing
so, we note that a slightly more complicated way of
computing xn, which ultimately also results in Eq. 4, was
described by Henze and Blair in 1931. We simplify their
presentation to calculate xn as follows: To any node, we
may attach three trees such that subtrees have pairwise
different numbers of nodes. We explicitly allow that a tree
has zero nodes, in which case we attach nothing—recall
that we have defined x0=1 above. For this case, we do not
have to take into account symmetry considerations, since
the subtrees must be pairwise different. So, we have
X
1þ jþ k ¼ n 1
i < j < k
xixjxk ¼ 16
X
iþ jþ k ¼ n 1
i 6¼ j; j 6¼ k; k 6¼ i
xixjxk ð9Þ
possibilities of doing so. Next, assume that we attach two
trees of the same size j, and a third tree of size i. There exist
xj þ 1
2
 
¼ 12 xj þ 1
 
xj ways to choose two trees of size
j, since this is a combination with repetition. We calculate
the number of tree as
X
i 6¼ j
iþ 2j ¼ n 1
xi
xjþ1
2
 
¼ 1
2
X
i 6¼ j ¼ k
iþ jþ k ¼ n 1
xixjxk þ
X
i 6¼ j
iþ 2j ¼ n 1
xixj
0
BBBB@
1
CCCCA
ð10Þ
Finally, all trees may have size xi. In this case, there exist
xi þ 2
3
 
¼ 1
6
xi þ 2ð Þ xi þ 1ð Þxi ¼ 16 xi
3 þ 3xi2 þ 2xi
 
ð11Þ
ways to choose three trees of size i. We calculate
X
3i¼n1
xi
3
 
¼ 1
6
X
i¼j¼k;iþjþk¼n1
xixjxk þ 3
X
i¼j;iþ2j¼n1
xixj þ 2
X
3i¼n1
xi
 !
ð12Þ
Note that if n−1 is not divisible by three, then all of
these sums are empty and, by definition, equal zero. Now,
we add these three values, and sort them: First, we put all
sums of products xixjxk . One can easily see that this equals
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1
6
P
iþjþk¼n1
xixjxk as desired: For the first sum on the right-
hand side of Eq. 10, there are three possibilities of choosing
two indices from i, j, k to be equal, as we can permute the
indices. Similarly, we can reproduce the second summand
of Eq. 4. Finally, the third summand directly comes from
Eq. 12, which completes the proof.
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2.2 The alternative messages of fungal genomes
2.2 The alternative messages of fungal genomes
In Gru¨tzmann et al. 2010119 we present a comparative study of AS in 26 fungal species. We
found that a greater part of fungal genes than previously expected are associated with AS, and
that a wide range of gene categories are aﬀected. Intron retention is the most frequent AS type
in the studied fungi, and skipped exons are rare in contrast to higher animals.
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Abstract: Alternative splicing (AS) is a cellular process that increases a cell’s coding capacity
from a limited set of genes. Although, AS is common in higher plants and animals, its preva-
lence and abundance in the whole eukaryote domain is unknown. We present a comparative
study of AS in 26 fungal species. The data suggest that a greater part of fungal genes than
previously expected are alternatively spliced (up to 14%). We ﬁnd evidence that in 26 of the
examined fungi, a wide range of gene categories are aﬀected. Hence, AS is a rather common
mechanism in many fungi.
1 Introduction
Alternative splicing (AS) is considered a frequent and complex process of eukaryote cells. AS is
a mechanism to enlarge a cell’s proteome, functions as a layer of gene expression regulation, and
increases phenotype variation while maintaining acquired function [Sor07]. Irimia et al. [IRPR07]
found that ancient genes show high rates of AS, and date simple forms of AS to ancestors of
plants, fungi and animals. There are many studies on AS in animals and higher plants, showing
signiﬁcant levels of AS aﬀected genes in these species (≈20% in Arabidopsis thaliana and Drosophila
melanogaster, ≈55% in mouse, ≥60% in human, based on ESTs [KMA07]) The question remains
how widespread and abundant AS occurs in the eukaryote domain, and how big the impact on
diﬀerent species’ lives is.
For fungi, only few studies address this issue on a genome-wide scale. Among some known fungal
species, AS occurs with varying but relatively low frequencies (0-5% of genes [IRPR07]). Due to a
reduced proteome and genome size, it is tempting to speculate that some biochemical pathways,
including splicing, are less complex in fungi than in higher animals. Fungi have smaller introns.
They also show extended consensus sequences for certain splicing signals, namely the 5’ splice site
and the branchpoint region [KDB+04]. These features facilitate a structural interpretation of intron
sequences, and they suggest low-complex AS patterns, both of which underline the role of fungi
as genetic models for (alternative) splicing. With regard to this model role, as well as for a better
understanding of the evolutionary dynamics of AS, we undertook a comparative investigation of
AS in 26 fungal species.
2 Methods
We downloaded gene annotations, genome and transcript sequences from NCBI’s GenBank, Ref-
Seq and dbEST databases (www.ncbi.nlm.nih.gov), from Broad Institute (www.broadinstitute.org) and
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from Joint Genome Institute (www.jgi.doe.gov) for 34 fungi. Mitochondrial and alien strain genome
sequences were excluded. After removing cloning adapters, repetitive and dust sequences, we built
spliced alignments using exalin [ZG06]. Since EST sequencing is error-prone, exons and introns
are only further used if their sequences were well aligned (≤ 10% mismatches, no mismatches in
5nt region of splice sites). Other criteria are least length (exons ≥ 6nt, introns ≥ 50nt) and splice
sites being from canonical (GT|AG) or known non-canonical (GC|AG, AT|AC) classes [KDB+04].
For each transcript, the alignment with best exalin score (min. score 20 bits) was selected.
3 Results
The number of available ESTs per species varies in a wide range (from 43 for P. marneﬀei to
277,147 for N. crassa). We counted the number of introns detected by these ESTs after mapping,
as described above. Relating it to the number of annotated introns (which are not necessarily the
same), we left out species that had less than 5% of annotated introns covered by ESTs. This left 26
species with suﬃcient EST coverage including three diﬀerent strains for P. brasiliensis). We ﬁnd
that 97-100% of all detected introns harbour the above mentioned allowed splice sites [KDB+04].
Non-canonical splice sites are rare among the remaining ones (0-3%), in accord with a previous
study [KDB+04]. This is a ﬁrst hint at the accuracy of our mapping and ﬁltering approach.
The sets of reliable introns and exons (possibly from diﬀerent mature mRNA isoforms) were ex-
amined for overlaps that are results of the basic AS modes: a) retained introns, that remain in
the mature transcript, b) skipped exons, that are spliced out, c) and d) alternative 3’ and 5’ exon
ends, where close alternative splice sites are used (alt. 3’/5’ss). Also see Figure 1. Thus, AS events
prediction is based on EST conﬂicts only and not on conﬂicts of ESTs with available annotated
intron/exon structures. Since availability and abundance of transcript data for fungi is a problem,
an isoform was already regarded as suﬃciently supported by only one EST. We counteracted false
positive predictions with the above mentioned strict ﬁlter criteria on alignments.
Figure 1: Basic alternative splicing types with constitutive exons (dark grey bars), alternative exons/exon
parts (light grey bars), introns (thin black lines) and alternative splicing ways (ﬂexed lines above and
below).
Among the 26 studied species we detected a varying number of AS events: from 0 and 2 events
for P. stipitis and S. pombe up to 796 and 870 events for C. immitis and C. neoformans (Table
1). We ﬁnd a very similar distribution of the AS types for all species. The most frequent events
are intron retention (48% of all AS events on average for all species), followed by alternative 3’ss
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phylum species genes introns mapped
ESTs
IR SE A5 A3 % AS
genes
% est.
AS gn.
Asco. A. niger 11197 24096 42831 167 7 53 46 1.9 5.1
Asco. C. immitis 10560 25503 58094 364 18 175 239 5.0 11.1
Asco. G. zeae 11578 25741 19215 44 1 15 17 0.5 3.5
Asco. M. grisea 14324 19662 76108 123 31 92 148 1.8 4.3
Asco. P. stipitis 5816 2577 18643 0 0 0 0 0 0
Asco. S. cerevisiae 6201 0 33628 2 0 2 9 0.2 0.2
Asco. S. pombe 5238 4757 6329 2 0 0 0 0 0
Basidio. C. neoformans 6617 36248 68966 506 31 126 207 8.3 14.5
Basidio. L. bicolor 18264 90677 29746 125 18 35 57 0.01 0.03
Basidio. U. maydis 6631 4900 34492 18 13 26 49 0.9 2.6
Micro. E. cuniculi 2029 15 25 0 0 0 0 0 0
Zygo. R. oryzae 17459 40515 11341 7 0 3 4 0.1 0.3
Table 1: Selection of studied species: phylum (Ascomycota, Basidiomycota, Zygomycota, Microsporidia),
species, gene and intron no. from public annotation, no. of mapped ESTs, AS events (intron retention,
skipped exons, alternative 5’ and 3’ splice site), percentage of genes with AS, extrapolated percentage of
genes with AS.
(29%), alternative 5’ss (19%) and skipped exons (4%). See Figure 2 for a pie diagram. These
results are in agreement with a former study on 14 fungi [MPNG08].
Figure 2: Distribution of the alternative splic-
ing types on average over all investigated species:
intron retention, skipped exons, alternative 3’
splice sites and 5’ splice sites.
We mapped the predicted AS events to genomic regions and found that on average 84.6% of the
events overlap with annotated genes. We calculated the percentage of genes presumably aﬀected
by AS (table 1). These raw numbers only have weak comparability between the species, as the
amount of available EST data is very diverse and the distribution of the transcripts across the
genome unknown. Hence, we normalized the AS percentages with the inverse fraction of EST
covered introns (7.7-58.1%). This yields an estimation of the AS rate of the complete genomes, for
better comparability. On average we ﬁnd that 4% of all genes of the studied fungi are aﬀected by
AS. There is a group with very low rates of AS (0-1% for S. cerevisiae, S. pombe, P. stipitis) and
a group with intriguingly high rates (11% and 14% in C. immitis and C. neoformans JEC21).
The 20% of genes with meaningful description (omitting descriptions like “hypothetical|unknown
protein”) are spread over a wide range of functional and structural categories: metabolism (malate
dehydrogenase, enolase), gene expression (ribosomal proteins, replication factors), cytoskeleton
(actin, tubulin folding), organelles and transport. In C. neoformans there is also a group of stress
related and other genes, which may hint at an altering environment of the fungus as it appears
during host infection.
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4 Discussion and Conclusion
Of 34 studied fungal species where genome sequences and EST data are publicly available, 26 have
acceptable amounts of data in terms of coverage of introns with aligned ESTs. Application of our
method with stringent ﬁlter criteria results in detection of introns with splice site distributions in
agreement with former results [KDB+04]. For most of the studied species we indeed ﬁnd several
events of AS, with AS rates per gene of 0-8% (1.6% on average). Careful extrapolation of the
amounts of AS events to a hypothetical intron coverage by ESTs of 100% results in an AS rate of
up to 11% and 14% of the genes in C. immitis and C. neoformans, respectively. Thus, the ’model
organism’ S. cerevisiae, having very few AS events, should be considered rather as an exception
than as a prototypic fungus in the context of splicing.
As EST data is sparsely and heterogeneously annotated, we could not exclude ESTs from alien
species strains directly. We hope to have circumvent this by strict ﬁlter criteria. Alien strain ESTs
have, e.g., a higher mismatch rate in EST-genome alignments. Nonetheless, this issue could have
led to false positive AS event classiﬁcations.
The data shown here and data for other non-animal organisms strongly support the view that
exon skipping is an AS type that is very speciﬁc to higher animals. In view of the elevated AS
rates compared to former studies [MPNG08], [IRPR07], and in view of the broad range of gene
categories aﬀected (metabolism, gene expression, cytoskeleton and others), we conclude that AS
is a rather common phenomenon in many fungi.
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2.3 Fungal alternative splicing is associated with multicellular
complexity and virulence – A genome-wide multi-species
study
In Gru¨tzmann et al. (accepted in DNA Research)120 we present a genome-wide comparative
study of AS in 23 fungi of diﬀerent taxa based on alignments of ESTs to genome sequences.
Using a robust random sampling strategy to estimate AS rates, we found that the average rate of
AS aﬀected fungal genes is 6.4%, and that Basidiomycetes show higher rates than Ascomycetes.
We showed that AS associates with higher multicellular complexity and pathogenecity.
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Table S3: Results of intron retention validation. The third column shows numbers of intron retention
events where at least one read that contains the retained intron has been spliced at another position.
species retained introns validated retained introns % validated
Ajellomyces capsulatus 51 47 92.2
Arthroderma benhamiae 1381 1368 99.1
Aspergillus nidulans 81 78 96.3
Aspergillus niger 323 321 99.4
Aspergillus oryzae 70 67 95.7
Botryotinia fuckeliana 19 14 73.7
Chaetomium globosum 1 1 100
Coccidioides immitis 664 661 99.5
Coprinopsis cinerea 173 171 98.8
Filobasidiella neoformans B-3501A 900 875 97.2
Filobasidiella neoformans JEC21 945 925 97.9
Fusarium oxysporum 33 30 90.9
Gibberella zeae 75 72 96
Laccaria bicolor 253 249 98.4
Magnaporthe grisea 222 211 95
Mycosphaerella graminicola 140 134 95.7
Neurospora crassa 511 491 96.1
Paracoccidioides brasiliensis Pb01 235 208 88.5
Paracoccidioides brasiliensis Pb03 134 117 87.3
Paracoccidioides brasiliensis Pb18 134 121 90.3
Penicillium marneﬀei 1 1 100
Phaeosphaeria nodorum 20 19 95
Phanerochaete chrysosporium 186 184 98.9
Podospora anserina 194 193 99.5
Rhizopus oryzae 26 25 96.2
Saccharomyces cerevisiae (yeast) 2 2 100
Schizosaccharomyces pombe (yeast) 3 3 100
Sclerotinia sclerotiorum 2 2 100
Trichoderma reesei 66 63 95.5
Ustilago maydis 34 34 100
mean 95.77
min 73.7
max 100
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Table S4: Pfam domains positively associated with alternative splicing.
Pfam accession Pfam description P value* Avg. EST
PF01479 Ribosomal S4 domain < 0.0007 21.8
PF09084 NMT1/THI5 like; involved in thiamine biosynthesis 0.0014 37.1
PF08520 fungal protein of unknown function (DUF) 0.0048 10.5
PF01946 Thi4 family; involved in thiamine biosynthesis 0.0089 30.3
PF01599 Ribosomal protein S27a 0.015 47.1
PF12586 protein of unknown function (DUF), Cryptococcus 0.045 2.0
* P-values include the Bonferroni correction
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Table S5: Pfam domains slightly positively associated with alternative splicing.
Pfam accession Pfam description P value* Avg. EST
PF01248 Ribosomal protein L7Ae / L30e / S12e / Gadd45 family 0.069 8.0
PF00163 Ribosomal protein S4 / S9 N-terminal domain 0.12 27.6
PF00900 Ribosomal family S4e 0.28 20.7
PF03073 TspO/MBR family; integral membrane protein that acts
as a negative regulator of gene expression in response to
oxygen/light
0.35 2.8
PF02453 Reticulon, know as neuroendocrine-speciﬁc protein (NSP),
associated with the endoplasmic reticulum
0.42 7.5
PF00428 60S acidic ribosomal protein 0.42 13.4
* P-values include the Bonferroni correction
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Table S6: Glucuronoxylomannan-related genes aﬀected by AS. Sequences were downloaded from
NCBI’s protein database using the search ”(glucuronoxylomannan) AND ”fungi”[porgn:txid4751]”.
species protein ID deﬁnition note
Cryptococcus neoformans
B-3501A
134108310 hypothetical protein
CNBB3380
”Glycosyltransferase GTB type”
Cryptococcus neoformans
JEC21
58263500 hypothetical protein ”Glycosyltransferase GTB type”
Cryptococcus neoformans
B-3501A
134107349 hypothetical protein
CNBA6810
”CAP59 mtransfer”, ”Cryptococcal
mannosyltransferase 1; pfam11735”
Cryptococcus neoformans
JEC21
58259209 capsular associated
protein
”CAP59 mtransfer”, ”Cryptococcal
mannosyltransferase 1; pfam11735”
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Table S7: AS aﬀected genes involved in stress response. Relation is based on blast similarity to P.
brasiliensis Pb01 genes TPS1 (NCBI accession EEH35656), HSP30 (EEH37950), and DDR48 (EEH33596).
species protein ID deﬁnition note
TPS1-relation
Cryptococcus neoformans
B-3501A
134108248 hypothetical protein
CNBB3070
”Glycosyltransferase GTB type”,
”GT1 TPS”, ”Trehalose-6-
Phosphate Synthase (TPS)
Cryptococcus neoformans
B-3501A
134116029 hypothetical protein
CNBI3400
”Glycosyltransferase GTB type”,
”GT1 TPS”, ”Trehalose-6-
Phosphate Synthase (TPS)
Cryptococcus neoformans
JEC21
58264051 trehalose-
phosphatase
”Glycosyltransferase GTB type”,
”GT1 TPS”, ”Trehalose-6-
Phosphate Synthase (TPS)
Cryptococcus neoformans
JEC21
58270702 alpha,alpha-
trehalose-phosphate
synthase (UDP-
forming)
”Glycosyltransferase GTB type”,
”GT1 TPS”, “Trehalose-6-
Phosphate Synthase (TPS)”
Laccaria bicolor 170098941 alpha,alpha-
trehalose-phosphate
synthase TPS1
subunit
”alpha,alpha-trehalose-phosphate
synthase TPS1 subunit”, Glycosyl-
transferase family 20; pfam00982”
Neurospora crassa 164428605 hypothetical protein
NCU00793
”hypothetical protein”, ”similar
to alpha,alpha-trehalose phos-
phate synthase subunit TPS3”,
”Glyco transf 20”
Podospora anserina 171695706 hypothetical protein ”Glyco transf 20”, ”GT1 TPS”,
”Trehalose-6-Phosphate Synthase
(TPS)
Trichoderma reesei 48707 alpha,alpha-
trehalose-phosphate
synthase
catalyzes UDP-glucose + D-glucose-
6-phosphate = UDP + alpha,alpha-
trehalose-6-phosphate
HSP30-relation
Coccidioides immitis 119194749 30 kDa heat shock
protein
”IbpA”, ”Molecular chaperone
(small heat shock protein)
Laccaria bicolor 170101017 predicted protein ”ACD sHsps-like”, ”Alpha-
crystallin domain (ACD) of
alpha-crystallin-type small(s)
heat shock proteins (Hsps)
Ustilago maydis 71019595 hypothetical protein
UM03881.1
”IbpA”, Molecular chaperone (small
heat shock protein)
DDR48-relation
Ajellomyces capsulatus 154277766 hypothetical protein
HCAG 05184
”similar to potential stress response
protein”, ”PTZ00110”, ”helicase;
Provisional”
Coccidioides immitis 119192856 predicted protein ”hypothetical protein”
Cryptococcus neoformans
B-3501A
134108310 hypothetical protein
CNBB3380
”Glycosyltransferase GTB type”
Mycosphaerella gramini-
cola
103686 - -
9
61
Table S8: NMD-related components and their homologs in NCBI HomoloGene database.
Note, HomoloGene contains data of only six fungi (S. cerevisiae, K. lactis, S. pombe, M. oryzae, N. crassa,
E. gossypii), hence the limited coverage of species.
NMD
factor
Homolo-
Gene ID
gene description species
UPF1 2185 NAM7 Nam7p S.cerevisiae
KLLA0B06435g hypothetical protein K.lactis
upf1 ATP-dependent RNA helicase Upf1 S.pombe
MGG 00976 regulator-nonsense transcripts 1 M.oryzae
NCU04242 ATP-dependent helicase NAM7 N.crassa
AGOS ABR022C ABR022Cp E.gossypii
UPF2 6101 KLLA0D13156g hypothetical protein K. lactis
NMD2 Nmd2p S. cerevisiae
upf2 nonsense-mediated decay protein Upf... S. pombe
MGG 06063 nonsense-mediated mRNA decay factor M. oryzae
NCU05267 hypothetical protein N. crassa
UPF3 11307 SPAC13G7.03 hypothetical protein S. pombe
39098 UPF3 Upf3p S. cerevisiae
KLLA0D03718g hypothetical protein K. lactis
AGOS AER204W AER204Wp E.gossypii
126047 MGG 03912 hypothetical protein M. oryzae
NCU03435 hypothetical protein N. crassa
CBP80 68864 STO1 Sto1p S. cerevisiae
KLLA0F17523g hypothetical protein K. lactis
AGOS AFR218W AFR218Wp E. gossypii
SPAC6G10.07 nuclear cap-binding complex large s... S. pombe
MGG 12123 cap binding protein M. oryzae
NCU04187 hypothetical protein N. crassa
CBP20 103828 CBC2 Cbc2p S. cerevisiae
KLLA0B10472g hypothetical protein K. lactis
AGOS AFL050W AFL050Wp E. gossypii
SPBC13A2.01c nuclear cap-binding complex small s... S. pombe
MGG 06296 nuclear cap-binding protein subunit... M. oryzae
NCU00210 nuclear cap binding protein subunit... N. crassa
Y14 3744 SPAC23A1.09 RNA-binding protein S. pombe
MGG 03740 RNA-binding protein 8A M. oryzae
NCU03226 hypothetical protein N. crassa
BTZ 127412 MGG 00982 hypothetical protein M. oryzae
NCU04270 hypothetical protein N. crassa
eIF4AIII 5602 FAL1 Fal1p S. cerevisiae
KLLA0A10659g hypothetical protein K. lactis
AGOS AER408W AER408Wp E. gossypii
SPAC1F5.10 ATP-dependent RNA helicase, eIF4A r... S. pombe
MGG 04885 ATP-dependent RNA helicase fal-1 M. oryzae
NCU01234 eukaryotic initiation factor 4A-12 N. crassa
127412 MGG 00982 hypothetical protein M. oryzae
NCU04270 hypothetical protein N. crassa
MAGOH 56794 SPBC3B9.08c protein mago nashi S. pombe
MGG 06859 mago nashi like 2 M. oryzae
NCU04405 mago nashi protein N. crassa
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SMG1 44191 smg1 Sm snRNP core protein Smg1 S. pombe
MGG 10740 sm snRNP core protein Smg1 M. oryzae
NCU09880 hypothetical protein N. crassa
PYM no entry for
fungi
hNAG no entry for
fungi
DHX34 no entry for
fungi
11
63
Supplementary Calculation S1
We downloaded all reads of S. pombe of the study on ﬁssion yeasts (24) from NCBI’s short read archive.
We converted the reads to fastq format with fastq-dump 2.0.5 using standard parameters (25). To estimate
the number of useful reads we ﬁltered them with the “lite” version of PRINSEQ (26) with the following
strict ﬁlter settings3:
prinseq-lite.pl -fastq in.fastq -trim_qual_left 25 -trim_qual_right 25 -min_len 50
-min_qual_mean 25 -ns_max_p 1 -noniupac -lc_method entropy -lc_threshold 70
-out_format 3 -out_good good_reads.fastq -out_bad bad_reads.fastq
This left 261,459,213 of the overall 307,223,097 reads (85%). The more reads there are available, the more
AS events can be detected and the higher is the “raw” AS rate of a species, i.e. dividing all detected AS
events by the number of genes. On the other hand, random sampling normalizes the rate. This is why
we found a slightly negative correlation (-0.31) of the number of reads with the ratio between the AS rate
from random sampling and the raw AS rate. For the species with the most EST data in our study (A.
benhamiae, 1,040,774 NGS reads), this ratio is 0.3, that means, the AS rate from random sampling (8.2%)
is around one third of the raw AS rate (27.4%). Similar, we assume the raw AS rate of S. pombe from
the Rhind et al. study (8.4% = 433 AS events/5144 genes) is a strong over-estimation of the real rate.
We suppose that the rate from random sampling would be much smaller than 2.5% (0.3 x 8.4%). This is
because the use of over 250 times more reads than for A. benhamiae likely has revealed many AS events
with a strong expression bias towards one isoform, which are not accounted for in random sampling. Thus,
the AS rate of S. pombe is clearly lower the mean AS rate of non-yeast Ascomycota (7.2%).
3For explanation of PRINSEQ parameters see http://prinseq.sourceforge.net/manual.html
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Supplementary Figures
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Figure S1: Dependence of alternative splicing rates on read amounts. Each point in the diagrams
represents data of one species. (A) AS rate from dividing the number of AS events by the annotated gene
number. (B) AS rate as average from repeated random sampling of transcripts. Note the logarithmic
scaling of the axes.
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Figure S2: AS rates versus maximal randomly sampled reads per locus.
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Figure S3: Mean splice site conservation Splice site (SS) conservation is calculated as information
content in bits as follows: For each intron and SS type (3’ and 5’), the SS regions of all introns were
stacked. The logarithm of each base’s frequency times the frequency is added and summed over all
sequence positions. Numbers of underlying introns are noted besides the chart symbols.
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2. PUBLICATIONS
2.4 Mutually exclusive spliced exons show non-adjacent and
grouped patterns
In Pohl et al. 2009121 we present an analysis of human and mouse mutually exclusive spliced
exons based on mappings of transcript sequences to genomic sequences. We detected more than
1000 MXEs per species, and report, to our knowledge for the ﬁrst time, a genome-wide frequent
presence of non-adjacent and cluster-spliced MXEs. As these special types comprise more than
95% of the detected events, the suitability of existing regulatory models of MXE splicing for
mammals are questioned.
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Abstract
The deciphering of the human genome provides the base for many bioinfor-
matic methods researching genome related matters. Splicing of mRNA is one
of the processes which depend on the genomic sequence. We present an analy-
sis of the results from a method that detects mutually exclusive spliced exons
in the genome. The method is based on transcript data mapped to the ge-
nomic sequence. Applying it to human as well as mouse genome we detected
more than 1000 mutually exclusive spliced exon pairs per species. The events
we analysed broaden the view on mutually exclusive regulated splicing and
reveal some unexpected characteristics.
1 Introduction
Alternative splicing (AS) of pre-mRNAs plays many diﬀerent roles and in
higher eukaryotes it is one regulatory mechanism for tissue-speciﬁc protein
variability [Bla00; Gra01]. Estimations of the scope of AS are often diﬀerent.
Most recent ones (based on short cDNA reads/mRNA-Seq data) show almost
every (95%) human multi-exon gene to undergo AS [Wan+08]. Traditionially,
four main AS patterns are considered: exon skipping, alternative acceptor or
donor site, intron retention [Fer+07; Kim+08]. Among the diﬀerent types of
AS, mutually exclusive exons (MXEs) constitute a comparatively rare, but
very intriguing type [Sam+08]. In its simple form, two internal exons are
spliced in such a way that one exon is excised, while the other one is kept
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within the mature mRNA (and vice versa), thereby linking the regulation
of diﬀerent exons. So far, MXEs have been usually assumed to be genomic
adjacent [Hol+06; Nag+06; Zhe+05]. One hypothesis about its functional
role is the selection of context speciﬁc sites within protein domains. Splicing
of MXEs has not been analysed in as much detail as more frequent types
of AS, e.g., exon-skipping or alternative exon boundaries [Bor+08; Hil+04;
ML03]. Nonetheless, such AS events contribute to our understanding of this
still largely unclear phenomenon. Several regulatory mechanisms for MXEs
have been proposed, including spliceosome incompatibility, steric hindrance,
docker-selector mechanism, or the regulation by splicing factors coupled with
nonsense-mediated decay [Smi05]. In this study we used a computational ap-
proach to infer about two thousand MXEs across more than 20,000 of the
mapped genes for human and mouse genome, respectively. We then compared
and contrasted our data for their compatibility with known AS patterns as
well as genomic features predicted by existing models for the regulation of
MXEs.
2 Results
All analyses are based on annotations of protein coding genomic regions re-
trieved from Ensembl (http://www.ensembl.org/). Onto these regions, we
mapped transcripts from the UCSC database (http://genome.ucsc.edu/;
4.8 million ESTs and 150,000 Fl-mRNAs). For the mapping we relied on the
transcript to genome alignments provided by UCSC [Kuh+09]. We consid-
ered a pair of exons to be mutually exclusive if all transcripts, mapped such
that they span the genomic region of both exons, exactly one of the exons is
included (for further details on mapping, ﬁltering and constraints please con-
tact authors). For about 20,000 human genes, we inferred 1,300 MXE pairs
(3.4% of all genes). In a similar study, we inferred 1,200 MXE pairs (3.3% of
all genes) for over 21,000 mouse genes. Comparing the detected pattern and
their features (genomic, transcriptional) with existing regulatory models, we
found for both studies that nearly all MXEs were not adjacent with respect to
their genomic location (99%, cf. Fig. 1.1), which is in contrast to the predicted
patterns of existing models. Furthermore, while we could not infer complex
patterns, such as docker-selector sites in the fruitﬂy gene Dscam [Ana+06],
we found MXEs to be involved in mutually exclusive splicing of more than
one exon simultaneously (cluster-spliced exons, cf. Fig. 1.1). None of the
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* (type 3) *
complex
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25%
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Figure 1.1: Representation of human (mouse) MXEs inferred within this
study. We divided MXE events into four distinct groups based on known
regulatory mechanisms and detected splicing pattern. Examples of splicing
pattern are shown at the bottoms of each type. Left hand side: three quarter
of all inferred mutually exclusive splicing events comprised single alternative
exons, split into adjacent (type 1) and non-adjacent (type 2) patterns. Mid-
dle: one quarter of inferred events featured the newly introduced mutually
exclusive splicing of exon clusters (type 3). Right hand side: we did not ob-
serve more complex patterns, e.g., like the selection of an exon, singled-out
from a cluster of possible MXEs in the Dscam gene of the fruitﬂy.
inferred MXEs obsessed the /AT and AC\splice site motifs for the minor
spliceosome. At ﬁrst glance, checking for orthologous genes we could infer
for 21% (11%) of human genes with adjacent events (non-adjacent) an event
for mouse as well. But a closer look at exon speciﬁc sequence conservation
remains for a more substantive reasoning on conservation of events. While we
could ﬁnd some previously reported events as for voltage-gated sodium and
calcium channel protein alpha subunits or human glycine receptor a2 gene
(SCNA, CACNA1d, GLRA2) there is as well a number of reported events not
among our results like KCNMA1, TCL6 [Cop04; Sam+08]. This is in particu-
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lar due to that mutually exclusive properties are frequently deﬁned on tissue
speciﬁc or transcript pair context while our approach requires global mutual
exclusivity. Frame shift analysis revealed higher frame conservation for adja-
cent than for non-adjacent MXEs. For the latter ones we also found a variable
number of enclosed constitutive exons reaching up to 67 with a strong bias
towards two.
3 Conclusions
One central outcome of this study is that non-adjacent exons constitute the
most frequent MXE event. Consequently, the inferred AS patterns, deter-
mined by transcript alignments, do not further substantiate existing models
and hence challenge their suitability as widely functioning mechanisms for
mutually exclusive splicing in higher eukaryotes, e.g., mammals. The model
incorporating spliceosome incompatibility found no evidence in this study,
the model incorporating steric hindrance is most conceivable for small introns
intervening MXEs, while the model incorporating docker-selector sites is not
conceivable for non-adjacent MXEs. The regulation by splicing-factors ac-
companied by the NMD mechanism remains a candidate for adjacent MXEs
and ought to be validated in future studies. Regulation of the new subtype
of cluster-spliced MXEs cannot be explained well by current models and new
hypotheses for AS regulation are necessary. Evolutionary origin, eﬀects on
evolvability [Che+06], splice site recognition as well as open questions raised
by our results will be discussed.
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In Pohl et al. 2013122 we review the current knowledge of MXE splicing. Emphasis is put on
bioinformatics methods to detect MXEs, as well as on deﬁnitions and nomenclatures of this AS
type. Molecular mechanisms of MXE splicing are discussed, especially in the light of adjacent,
non-adjacent, grouped, and cluster-spliced subtypes of MXEs.
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Alternative  splicing  (AS)  of pre-mRNAs in  higher  eukaryotes and several viruses  is  one major  source  of
protein diversity.  Usually,  the  following  major  subtypes  of AS  are  distinguished:  exon skipping,  intron
retention, and alternative  3′ and 5′ splice sites.  Moreover,  mutually  exclusive  exons  (MXEs)  represent  a
rare subtype.  In  the  splicing  of  MXEs,  two  (or more)  splicing  events  are  not independent  anymore,  but
are executed or  disabled  in  a  coordinated  manner.  In  this  review,  several  bioinformatics  approaches  for
analyzing MXEs  are  presented  and discussed.  In  particular,  we revisit  suitable  deﬁnitions and nomencla-
tures, and bioinformatics  tools for  ﬁnding MXEs,  adjacent  and non-adjacent  MXEs,  clustered  and grouped
MXEs. Moreover,  the  molecular  mechanisms  for  splicing  MXEs proposed  in  the  literature  are  reviewed
and discussed.
© 2013 Elsevier Ireland Ltd. All rights reserved.
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1. Introduction
1.1. Molecular biology background
In addition to the genetic code, several other codes are used
by the living cell at the molecular level, for example, the calcium
Abbreviations: AS, alternative splicing or alternatively spliced; MXE, mutu-
ally exclusive exon; EST, expressed sequence tag; NMD, nonsense mediated mRNA
decay; ORF, open reading frame; Dscam, Drosophila Down Syndrome Cell Adhesion
Molecule.
∗ Corresponding author. Tel.: +49 3641 949581.
E-mail addresses: m.pohl@uni-jena.de (M.  Pohl),
ralf.bortfeldt@agrar.hu-berlin.de (R.H. Bortfeldt), konrad.g@uni-jena.de
(K. Grützmann), stefan.schu@uni-jena.de (S. Schuster).
oscillation code and the code used for signaling among plants by
volatile chemicals. In eukaryotes one of these is the splicing code,
by which the cell decides which sequence parts are ﬁnally used
(Choudhary and Krithivasan, 2007; Barbieri, 2008; Barash et al.,
2010; Reddy et al., 2012).
In the post-genomic era, alternative splicing (AS) of pre-mRNAs
in  higher eukaryotes got in the focus of research as one major
source of protein diversity (Black, 2000; Graveley, 2001; Kim
et  al., 2008; Nilsen and Graveley, 2010; Chen et al., 2012a). AS was
discovered in adenoviruses (Berget et  al., 1977) and also occurs
in  several other viruses such as cytomegalovirus (Gatherer et  al.,
2011). Protein variability contributes to a high complexity of higher
eukaryotes while keeping the numbers of genes relatively low. AS
is  a means to change proteins, in dependence on gender, develop-
mental stage or environmental conditions and can affect binding
0303-2647/$ – see front matter ©  2013 Elsevier Ireland Ltd. All rights reserved.
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properties, intracellular localization, enzymatic activity and many
more properties of proteins (Stamm et  al., 2005; Yap and  Makeyev,
2013). Estimations raised from one third up to 95% of  human genes
affected by AS, with other mammals showing similar high AS lev-
els  (Florea, 2006; Pan et al., 2008; Wang et al., 2008). Alternative
splicing and splicing in general is a major problem in gene ﬁnding
in  eukaryotes because it may  disrupt ORFs (Pohl et al., 2012).
The potential for variability is enormous. For instance, the
human calcium-activated potassium channel subunit alpha-1 gene
and the three neurexin genes could potentially generate 500 and
more than 2000 different protein isoforms, respectively, by differ-
ent ways of splicing (Black, 1998; Tabuchi and  Südhof, 2002). The
Drosophila Down Syndrome Cell Adhesion Molecule gene (Dscam)
has several sets of cassette exons with one of them involving 48
alternative exons among which one is selected (Graveley, 2005;
Anastassiou et al., 2006; Meijers et al., 2007; Olson et al., 2007;
Hemani and Soller, 2012; Wang et al., 2012). This leads to 38,016
theoretical splicing variants.
AS is thought to lower selective pressure on gene sequences
allowing a higher trial and error rate by mutations in one of the
isoforms without compromising the acquired functionality of the
other isoform (Boué et  al., 2003; Chen et al., 2006; Noh et  al., 2006).
The  apparent evolutionary advantages of AS require, however, sig-
niﬁcant energetic and metabolic costs because the spliceosome,
which performs the splicing reaction, is a large complex of  pro-
teins and RNA including up to several hundreds of  constituents
(Jurica and Moore, 2003; Kielbassa et  al., 2009; Bortfeldt et  al.,
2010; Hoskins et  al., 2011). Given the enormous effort to assem-
ble  such complicated molecular machinery it can be assumed that
the  beneﬁt of  transcript ﬂexibility outweighs the biochemical costs.
In contrast, some organisms such as many plants, seem to have
achieved their level of protein variability mainly by gene duplica-
tions i.e., an increase in genome length (Kopelman et al., 2005).
The ability to cope with stress is widely enhanced via trans-
criptome plasticity (Mastrangelo et al., 2012). Moreover, the
involvement and prevalence of AS in many diseases is becoming
increasingly clear. Hence, protein variability as  generated by alter-
native splicing is of great medical and  biotechnological importance
because different isoforms are often associated with diseases such
as cancer (Hernandez-Lopez and Graham, 2012) or  with the distinc-
tion between intracellular and extracellular enzymes (Andreassi
and Riccio, 2009). This renders AS and  its regulation a poten-
tial therapeutic target (Mount and  Pandey, 2005; Garcia-Blanco,
2006; He et  al., 2009; Tazi et al., 2009, 2010; Douglas and Wood,
2011; Germann et  al., 2012; Hernandez-Lopez and Graham, 2012;
Sanchez-Pla et  al., 2012).
Several attempts for general AS annotations have been pre-
sented (Xing et al., 2004; Nagasaki et al., 2006; Sammeth et  al.,
2008; Kroll et  al., 2012). Among the well-known subtypes of AS are
exon skipping (Sorek et al., 2004b), intron retention (Wang et  al.,
2006), alternative 5′ splice sites (Dou et  al., 2006; Bortfeldt et  al.,
2008; Hiller and Platzer, 2008), alternative 3′ splice sites (Bortfeldt
et al., 2008; Hiller and Platzer, 2008). A less abundant subtype of
AS is represented by mutually exclusive exon (MXE) splicing.
MXEs are characterized by splicing of exons in a coordinated
manner such that two or  more splicing events are not independent.
As the name “mutually exclusive” indicates, exactly one out of  two
exons (or one group out of  two exon groups) is retained, while the
other one is spliced out.  Sammeth (2009) applies the term in a less
strict way, allowing the case that none or all  of the exons under con-
sideration are retained. In contrast to other variants of alternative
splicing, mutually exclusive splicing can leave the size of the protein
unchanged provided that the exchanged sequence is of the same
length and does not  introduce a premature stop codon. Depend-
ing on the similarity of exchanged exon sequences, minor changes
as in subtle alternative 5′ and 3′ splicing events or major changes
of whole protein domains as in exon skipping are possible. In case
of  minor protein sequence changes, MXEs may  provide an advan-
tage to many types of  proteins, such as  ion channels, because the
spatial structure is preserved, while the protein exhibits an altered
function (Birzele et al., 2008a). Interestingly, another RNA process-
ing mechanism, RNA editing, can also occur in a mutually exclusive
manner as  shown for the TPH2  gene (Grohmann et  al., 2010) result-
ing in a similar effect as mutually exclusive exon splicing.
A  common assumption is that MXEs have originated from exon
duplication and, hence, are highly similar (Letunic et al., 2002;
Copley, 2004; Sorek, 2009; Pillmann et al., 2011). Accordingly, some
authors (Stephan et al., 2007; Pillmann et  al., 2011)  deﬁne MXEs
based on similar length and sequence. In our opinion, these criteria
are not necessary. The term “mutually exclusive” only implies that
exons do not occur together but does not refer to length, sequence
or  exon numbers. In general, also a group (cluster) of  exons can
be mutually exclusive with respect to another group (cluster) of
exons. Such cases should be distinguished from exon cassettes
where exactly one out of  several exons is retained in the mature
transcript, such as  in the Dscam gene in Drosophila. However, the
terminology is not used consistently among researchers, MXE were
previously also termed as  “exon clusters” (Pillmann et  al., 2011)  or
“cassette exons” (Stephan et al., 2007).
MXEs turned out to be very promising candidates for gener-
ation of highly diverse but speciﬁc processes (Anastassiou et al.,
2006; Soom et al., 2008). The alternative selection of exons enables
the encoding of a whole class of proteins with similar scaffold and
similar length but with highly speciﬁc functionality. Beside the
above-mentioned Drosophila Dscam gene, examples of biological
relevance are provided by the voltage dependence of ion channels
(Soom et al., 2008) and calcium sensitivity of muscle proteins in
higher animals (Waites et  al., 1992). Like other AS types, MXEs
proved to be of medical relevance, e.g., at regulation of  expression
levels of the mammalian pyruvate kinase M  isoforms (Chacko and
Ranganathan, 2009b; Chen et al., 2012b). Examples of  MXEs have
been described in human (Soom et  al., 2008), mouse (Chacko and
Ranganathan, 2009a), rat (Gustafson et  al., 1993), chicken (Waites
et  al., 1992; Chacko and Ranganathan, 2009a), cow (Chacko and
Ranganathan, 2009b), nematode (Johnson et al., 2003) and other
species.
1.2. Bioinformatics resources for analyzing MXE  splicing
As biochemical analyses are expensive and time consuming,
computational approaches have attracted an ever increasing inter-
est. Accordingly, AS is an important topic in bioinformatics (Dou
et al., 2006; Zavolan and van Nimwegen, 2006; Hiller et  al., 2007;
Bortfeldt et al., 2008; Hiller and Platzer, 2008; Sammeth et  al., 2008;
Busch and Hertel, 2012; Chen et  al., 2012a; Sanchez-Pla et  al., 2012).
To  date many resources on AS emerged thanks to the growing
amount of  sequence and alignment data, in spite of incomplete-
ness and considerable noise within the data (Black, 2003; Lareau
et  al., 2004; Chen et al., 2012a). Relevant databases that emerged in
the  context of  MXE are MAASE (Zheng et al., 2005), HOLLYWOOD
(Holste et al., 2006), ASAP II  (Kim et al., 2007), ECgene (Lee et al.,
2007),  Ensembl (including former ASD/ATD/ASTD/AEdb projects
(Koscielny et al., 2009), SPLOOCE (Kroll et al., 2012).
Also, the assembly of the spliceosome has been described by
bioinformatics approaches (Kielbassa et al., 2009; Bortfeldt et  al.,
2010; Hoskins et  al., 2011). Different types of  the spliceosome were
suggested to produce MXE  splicing patterns (see Section 4). Beside
the  major spliceosome, a minor spliceosome can process splice sites
that have distinct consensus sequences and are incompatible with
the  major spliceosome (Will and Lührmann, 2005).
In this review, we  discuss several bioinformatics approaches for
analyzing MXE  splicing. In particular, we  will focus on appropriate
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Fig. 1. Graphical and symbolic representations of different AS patterns. Gray boxes, exons; thick solid horizontal lines, introns; ﬂexed lines, splice junctions. Explanation,
see text.
deﬁnitions, present bioinformatics tools for ﬁnding MXEs, out-
line Boolean approaches, and compare adjacent with non-adjacent
MXEs and clustered with non-clustered MXEs. Moreover, we will
discuss molecular mechanisms leading to MXEs.
2.  Nomenclatures and deﬁnitions
2.1. Established approaches
A  widely used graphical representation of AS events shows the
alignments of transcripts as boxes representing exons connected by
individual links for  each isoform (Fig. 1). Early in the analysis of AS, it
became clear that standardization of  the nomenclature for AS forms
is  important (Zavolan and van Nimwegen, 2006). Since then, some
attempts have been made without leading to a broadly used and
accepted nomenclature. Nagasaki et al. (2006) introduced number
vectors based on bit arrays where exonic regions are denoted with
‘1’  and intronic regions are denoted with ‘0’.  Sammeth et al. (2008)
suggested a general nomenclature for AS by representing trans-
cripts as  sequence of splice sites connected by symbols for exons
and exon–exon junctions. Recently, Kroll et  al. (2012) introduced a
character-based syntax to describe results achieved with the anal-
ysis of bit arrays by regular expressions. An overview of  these
notations is given in Fig. 1.
Even more notations have been suggested in the literature.
Malko et  al. (2006) used strings of  one-character-codes for basic
alternative events. Based on the exon–intron structure of isoforms,
Riva and Pesole (2009) computed unique signature strings as a
basis for an unambiguous nomenclature which facilitates database
searches.
One drawback of such nomenclatures is that transcripts are
considered and represented only individually, such that possi-
ble dependencies between splicing events remain hidden. The
resulting codes describing the splice patterns make it presently
cumbersome to detect such dependencies because they have to
be  decoded and compared ﬁrst. Additionally, for a more compre-
hensive splicing picture more than two  transcript variants must be
considered. One solution to this is the search for  subgraphs within
splicing graph representations of transcript isoforms (Sammeth,
2009).
In the strict deﬁnition, MXEs should be perfectly mutually exclu-
sive, as the name suggests. In many studies, only two transcripts
are considered, e.g. in two  tissues or developmental stages. How-
ever, MXEs found in this manner need not be MXEs when taking
more abundant transcript data into account. Thus, the term MXE
is  relative with respect to the abundance of known transcripts at
a gene locus, which in turn depends on how many different con-
ditions are studied. This is the case in the example of TCL6, where
speciﬁc tissues show indeed exclusive patterns while on the basis
of  all known transcripts the pattern is lost (Sammeth et al., 2008).
We  suppose that this also applies to KCNMA1 (Soom et  al., 2008).
The more detailed analysis by Nilsen and Graveley (2010) shows
that on the basis of  more transcripts, the exons of KCNMA1 are not
perfectly exclusive, because there are transcripts containing both
mutually exclusive exons.
Summarizing these considerations, it might be worthwhile
relaxing the strict deﬁnition of MXEs in that a certain percentage
of  non-exclusive events are allowed. In living organisms in general,
many exceptions and deviations occur, for  example in the  num-
ber of  teeth in humans. The clover plant usually has three leaves
with a rare deviation showing four leaves. These deviations do  not
prevent the individual to be classiﬁed in the general type (e.g.,
human, clover, etc.). Analogously, AS events could be deﬁned as
context speciﬁc MXEs, allowing a certain percentage of  cases, that
are not mutually exclusive when compared across different condi-
tions, e.g., developmental stages, tissues or disease states. However,
80
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it is difﬁcult to deﬁne a biologically well-founded value for such a
threshold.
2.2. Adjacent MXEs and non-adjacent dependencies
In  a genome wide study of  MXE events in humans, we detected
a number of non-adjacent MXEs (Pohl et al., 2009). This contra-
dicts  the intuitive assumption that MXEs – which are expected
to  originate from exon duplication – should usually be in direct
genomic neighborhood (Letunic et  al., 2002; Copley, 2004). Glauser
et al. (2011) found dependencies between individual sites even in
the case of non-adjacent alternatively spliced exons in Caenorhab-
ditis elegans slo-1,  which is in line with our ﬁndings. This is also
supported by results presented in the ASTALAVISTA study (Foissac
and Sammeth, 2007). Non-adjacent, mutually dependent exons
have also been reported recently by Kroll et al. (2012) (see the
pattern “-s-E-s-” in Table 3 in that reference). That indicates that
only approaches and nomenclatures considering mutual (including
long-ranging) dependencies among exons that include a constitu-
tive exon in between will have a  chance of success in predicting
the  full splicing picture, all the more as the line between differ-
ent AS types is not clear-cut (Sammeth et  al., 2008). For example,
distal exclusions are a combination of skipped exons, and “Twin-
trons” are formed by co-occurring alternative 5′ and 3′ ends
(Fig. 1).
2.3. A Boolean nomenclature
In case of clustered and/or non-adjacent MXEs, it may  be difﬁ-
cult to grasp the dependencies among the exons. Then, it is helpful
to  formalize the notation. For example, if either an exon A is used
or  a cluster of two exons B and C, we may  write: A ⊕  (B ∧ C) (with
⊕ denoting the exclusive disjunction, XOR). However, it is more
convenient to attach indices to splice sites rather than to exons,
because the possible overlap of  exons (such as  in the cases of
intron retention or alternative ends) is easier to recognize in that
way.
Denoting the splice sites in the above example by 1–6, the nota-
tion is E1,2 ⊕ (E3,4 ∧ E5,6),  where Ei,j stands for  an exon between
splice sites i  and j. The usual case of  one pair of MXEs would then
be written as  E1,2 ⊕  E3,4.
Also alternative 5′ and 3′ ends can now be described in a unique
way by this notation. Assume, for example, that B includes A and
three further nucleotides at the 3′ end, then A ⊕ B describes a tan-
dem donor splice site AS event, not  an  MXE. Applying splice site
indices we obtain the distinct E1,2 ⊕  E1,3 for  the alternative exon
end (Fig. 1C–E).
When these Boolean expressions get rather long and complex,
it is useful to condense them to the so-called disjoint normal forms.
For example, the above-mentioned case of non-adjacent MXEs
might be written ﬁrst  as (E1,2 ∧ E3,4)  ⊕  (E3,4 ∧ E5,6). This can be sim-
pliﬁed to the expression (E1,2 ⊕  E5,6) ∧ E3,4.
It is worth noting that not only MXEs, but also other AS
events can be described in this way.  For example, the notation
(E1,2 ∧ E5,6)  ⊕  (E1,2 ∧ E3,4 ∧ E5,6)  describes the usual exon skipping
event (Fig. 1A). Interestingly, there are cases that are neither perfect
MXEs nor classical exon skipping, but more complex dependen-
cies. Sammeth (2009) considered such dependencies earlier, using
another notation, and included more complex dependencies into
the class of MXEs (Fig. 6 in Sammeth, 2009), while we advocate to
use this term for  the “exclusive or” case only (Fig. 1F). For exam-
ple, E1,2 ∨  E3,4 describes the situation where exon A or  B can  be
skipped but also the case may  occur where both exons are used. It
excludes, however, that both exons are skipped. Conversely, there
may  be the case ¬(E1,2)  ∨ ¬(E3,4). Another notation for this case is
∅  ∧ (E1,2 ⊕ E3,4).
In doing so, Sammeth et  al. (2008) proposed a Boolean-like
notation in which the splice sites rather than exons are used
as  elementary units, denoted by numbers. For example, “1-2∧,
3-4∧” describes two mutually exclusive exons (Fig.  1F), where
the  hyphens stand for exons, the caret stands for introns and
the  comma  separates isoforms. Such annotation will perfectly
describe each isoform, but dependencies among splicing events
are included only indirectly. This holds for  other approaches like
binary array based number vectors (Nagasaki et  al., 2006)  or
isoform signatures (Riva and Pesole, 2009). Dependencies that
span constitutive positions (Glauser et al., 2011)  will get lost.
The  intuitive description used  by SPLOOCE (Kroll et al., 2012) is
inappropriate for cases with more than two  dependent isoforms
(Fig. 1G). Our suggestion is more general in that it describes more
than two  possibilities (e.g. E1,2 ⊕ E3,4 ⊕  E5,6) at once and enables
the explicit inclusion of  mutual dependencies between splicing
events.
3. Detection
The detection of AS can be well distinguished by the three
data sources they depend on, namely microarrays, RNA sequence
alignments and mere DNA or RNA sequences. Microarrays as a
long consolidated methodology still remain useful and accurate
for transcriptomic analysis with low input requirements, while
RNA-seq technology complements and extends microarray mea-
surements for novel discoveries. Sequence based approaches utilize
existing knowledge about splicing and its  regulation, e.g. sequence
and secondary structure motifs, for investigation of pure genomic
sequence data (Hallegger et  al., 2010; Raghavachari et al., 2012;
Sanchez-Pla et al., 2012).
• Microarrays are useful for identiﬁcation and expression anal-
ysis of predicted exons (Exon arrays), in scanning areas for
reported and novel exon usage (tiling arrays) and for measure-
ment of  known exon junctions (splicing arrays). Exon junctions
are  sequences after joining at splice sites. Microarray approaches
proved to be useful although being strongly dependent on pre-
vious knowledge on gene transcription (Castle et  al., 2008;
Gonzalez-Porta et  al., 2012; Raghavachari et al., 2012; Sanchez-
Pla et al., 2012)
• Alignment based analysis is widely applied in identiﬁcation of
novel splicing events de novo (Sacomoto et  al., 2012) or by align-
ment to genomes (Wang et al., 2008, 2010; Zhou et al., 2012)
and in combination with a variety of  data reduction techniques
like number strings (Sammeth et al., 2008), isoform signatures,
Boolean arrays (Nagasaki et  al., 2005, 2006) and regular expres-
sions (Kroll et  al., 2012)
• De  novo sequence analysis
◦ Similarity based search depends on assumptions from knowl-
edge about former described splice events like associated
sequence motifs. One assumption is that mutually exclusive
exons encode regions of  the same structural part of  the protein
product. This precondition provides restrictions to the search
for candidate exons concerning their length, splice site conser-
vation and reading frame preservation, and overall homology.
Mutually exclusive exons that are not homologous and not of
about the same length will not be found (Sorek et al., 2004b;
Stephan et al., 2007; Pillmann et al., 2011).
◦ RNA secondary structure prediction applies the principles of
sequence similarity search on the structural level, such shif-
ting  the focus from sequence level to the regulatory relevant
structural formation (Washietl et al., 2005; Raker et  al., 2009;
Reuter and Mathews, 2010; Yang et al., 2011).
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B) Coordinated splicing
     control coupled to NMD
D) Changes in secondary structure
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Fig. 2. Various regulatory mechanisms for MXE  splicing as proposed in the literature. (A) Spliceosome incompatibility: either one exon is excluded by the U1 spliceosome
or another exon is  excluded by the U12 spliceosome. (B) Coordinated splicing control coupled to NMD: exons are  regulated by trans-acting splicing factors (e.g. PTB),  which
suppress splicing of one exon while enhancing splicing of  the other one. Mis-spliced isoforms that contain both exons incorporate premature termination signal (PTS) and are
degraded by non-sense mediated mRNA decay (NMD). (C) Steric hindrance: for  introns shorter than 60 bp the spliceosome uses one splice site while the other one cannot be
used because it is too close. (D) Change in secondary structure: MXE splicing is  brought about by formation of loops in the pre-mRNA. S: suppressor. For further explanation,
see text.
4. Mechanisms leading to  mutual exclusion of  exons
Several general mechanisms for  realizing mutually exclusive
splicing have been proposed (Smith, 2005; Nilsen and Graveley,
2010; Jin et al., 2011; Pervouchine et al., 2012; Hemani and Soller,
2012) (Fig. 2):
• Spliceosome incompatibility (Fig. 2A): combinations of alterna-
tive splice sites can imply that the mutually exclusive exons are
recognized and spliced by different spliceosomes, i.e. the U1 or
U12 spliceosome (Burge et  al., 1998; Letunic et  al., 2002; Will
and  Lührmann, 2005). Beside the major spliceosome, a minor
spliceosome, in which the subunits U1 and U2 are replaced by
U11 and U12, can process splice sites that have distinct consen-
sus sequences and are incompatible with the major spliceosome
(Will and Lührmann, 2005). Thus, each type of the two different
spliceosomes is compatible with only one of the MXEs.
• Coordinated splicing control coupled to  NMD  (Fig. 2B): if  exons
are  regulated by trans-acting splicing factors, which suppress
splicing of one exon while enhancing splicing of  the other one,
the mature mRNA can be mutually exclusive (Jones et al., 2001;
Spellman et  al., 2005). To avoid mis-splicing in the absence of
splicing factors, isoforms that contain both exons incorporate
premature stop codons and  are potentially degraded by non-
sense  mediated mRNA decay (NMD), as  was suggested also for
subtle tandem donor splicing (Bortfeldt et  al., 2008). This  mech-
anism has been described for the growth factor receptor FGFR2
(Jones et al., 2001), -tropomyosin (Spellman et  al., 2005), and
the channel CaV1.2 (Tang et al., 2011).
• Steric hindrance (Fig. 2C): for  introns shorter than 60 bp
the spliceosome cannot perform the necessary structural
arrangements, hence, one splice site is used and the other one is
skipped due to steric hindrance (Smith and Nadal-Ginard, 1989;
Mullen et  al., 1991; Kennedy and Berget, 1997). Thus, by skipping
one exon an intron is generated that is long enough to become
properly spliced.
• Formation of secondary structure elements (Fig. 2D):
◦  Induced steric hindrance: loop formation within long introns
may  bring splice sites in close proximity preventing splicing in
a similar manner as steric hindrance at short introns (Jin et  al.,
2011).
◦  Docker-selector pairing, Looping out: a group of exons, each pos-
sessing a similar upstream selector site, can compete in forming
a  secondary structure by binding, forming intronic RNA pair-
ings,  to a complementary docker site upstream of all these
exons  (Miriami et al., 2003; Graveley, 2005; Anastassiou et al.,
2006; Yang et al., 2011). Each exon is normally bound by a
repressor, which inhibits the inclusion of the exon. Base pairing
of  the docker with one selector site activates the exon down-
stream adjacent to the selector by releasing the repressor. As
only one loop can  be formed there will be one exon included
exclusively. This is known from Drosophila as  docker-selector
principle (Schmucker et al., 2000; Graveley, 2005; Anastassiou
et  al., 2006; Olson et  al., 2007). This mechanism may  have
occurred by exon duplication and subsequent mutations.
◦  Approximation of cis elements: RNA pairing directs control ele-
ments ﬂanking an exon into close physical distance, thus
forming a splicing activating complex (Muh et al., 2002; Yang
et  al., 2011).
Many of these mechanisms suggest that MXEs are adjacent
to  each other in the genome. Moreover, it has been proposed
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that regulatory microRNAs and  epigenetic mechanisms such as
chromatin structure and nucleosome organization play a role in
exon choice (Luco and  Misteli, 2011; Huang et  al., 2012). One may
argue that this implies a splicing code at a higher level.
Findings about non-adjacent and clustered MXEs are of  interest
in  view of the relevance of the above-mentioned mechanisms of
MXE  splicing proposed in the literature (Fig.  2). Spliceosome incom-
patibility seems unlikely in the case of  non-adjacent MXEs. This is
because the entire region between the two MXEs would have to be
removed (a contradiction to the assumption that it includes consti-
tutive exons), unless the constitutive exons would be recognized
by both spliceosomes. Steric hindrance is prevented if  constitutive
exons exist between the MXEs because these MXEs would then be
sufﬁciently distant. Also the mechanism via NMD  and trans-acting
splicing factors is unlikely, since such a mechanism would require
the following conditions: (a)  retention of both alternative exons
should cause a frame shift leading to NMD; (b) removal of  both
alternative exons should cause a frame shift leading to NMD  (con-
ditions a and b would guarantee mutual exclusivity); (c) splicing
of  the ﬁrst alternative exon should not cause a frame shift in order
to  preserve functionality of  the constitutive exons in between the
alternative exons. However, these conditions contradict each other,
since they imply that  the second alternative exon would cause a
frame shift both when absent and present. The docker–selector
principle would not work either because constitutive exons must
not be situated in the loop occurring in that mechanism.
As mentioned in the Introduction, the Dscam gene has a
set involving 48 alternative exons (Graveley, 2005). This led to
hypotheses about the possibility of more than two mutually
exclusive exons (or exon groups) within one and  the same gene
in the human genome. Such cases would be an  indication of
docker–selector pairing or  related mechanisms. However, in men
and mice, we found no more than two mutually exclusive parties
(Pohl et al., 2009). Such cases had not been detected by other
groups either, nor have they been considered in splicing databases
for the human genome. Therefore, databases like ASAP or HOLLY-
WOOD are designed for mutually exclusive splicing with exactly
two exclusive exons and do not cover mutually exclusive exon
groups. Nonetheless, the docker–selector mechanism cannot be
excluded as hypothetical splicing mechanism for adjacent MXEs. As
for non-adjacent MXEs, in our opinion, the existence of a hitherto
unknown mechanism has to be considered.
5. Evolutionary conservation
In  general, functional AS events conserved across species tend
to preserve the reading frame (Sorek et al., 2004a; Kim et al., 2008).
Events shifting the reading frame imply NMD  and are hardly con-
served between humans and mice (Zhang et al., 2009). By utilizing
AS, evolution may  currently be working on adoption of  further
functions for the concerned genes.
In future investigations, it would be interesting to analyze the
difference in conservation between more frequent and less fre-
quent MXE  isoforms. From an  evolutionary point of view, one can
expect that one of the two MXE  isoforms shows a  high sequence
conservation on the DNA level to maintain the biological function of
the protein (Boué et al., 2003). The other form (probably the minor
form) may  be less conserved, to serve as a “playground of evolu-
tion”. Similar observations were made for skipped exons (Xing and
Lee,  2006) and subtle tandem donor AS (Bortfeldt et  al., 2008). Note
that a partially low EST coverage might have prevented the detec-
tion  of some orthologous isoforms possibly serving this purpose.
Since non-adjacent MXEs are less conserved and tend to shift the
reading frame, they are more likely to be a “playground of evolu-
tion” than adjacent MXEs. Analogous hypotheses have been put
forward for  intron retention and alternative ends (Sorek, 2007;
Tarrío et al., 2008). In contrast, in situations where both MXEs are
equally important, as  it appears to be the case for ion channels, the
degree of conservation is not likely to differ. In fact, the instances
of  adjacent MXEs within the human genome we found within our
studies, were predominantly assigned to ion channels (Pohl et  al.,
2009).
A  following step would be to investigate the impact of MXE
splicing on protein function. To do so, it is useful to compare the pro-
tein structures resulting from the alternative transcripts (Birzele
et al., 2008a,b). However, at  present for many proteins no structural
information is available.
6. Conclusions
Here we have reviewed approaches to analyze a rare subtype
of  alternative splicing (AS), termed mutually exclusive exon (MXE)
splicing. We  have discussed various approaches and nomenclatures
in this context. MXE splicing is the only type of AS that can maintain
the size  of  the protein introducing a quasi-exchange, provided that
the  exons are (nearly) of the same length.
It is often assumed that MXEs – which are expected to origi-
nate from exon duplication – should usually be in direct genomic
neighborhood (Letunic et  al., 2002; Copley, 2004). However, there
is  no reason to exclude non-adjacent MXEs. Hence, only approaches
and nomenclatures considering mutual (perhaps long-ranging)
dependencies within complete genes will have a chance of success
in deciphering the full splicing picture.
In many studies often only two  transcripts (e.g. in two  tissues or
developmental stages) are considered. MXEs found in this manner
need not to be MXEs when taking more abundant transcript data
into  account. Thus, the term MXE is relative; it depends on how
many different conditions are studied and the regulation mecha-
nism might not work in a perfectly strict manner (Tang et al., 2011).
Summarizing these considerations, it may be worth relaxing the
rigid deﬁnition of MXEs in that a certain fraction of non-exclusive
events is allowed. Nevertheless, as many different tissues as possi-
ble should be analyzed as  this for example allowed the detection of
switch like skipped exons (Wang et al., 2008). In clustered MXEs,
a strict dependence between the exons within each cluster occurs.
Such a dependence can  also occur in other types of  AS. For example,
in some events of exon skipping, a strict correlation between two
consecutive exons was found (Sammeth et  al., 2008).
The analysis of  MXEs by various bioinformatics techniques
is  likely to be very helpful in diagnosing diseases and tailo-
ring pharmaceuticals in personalized medicine. For example, the
knowledge of receptor variants can help identify new drug targets.
The knowledge of variants of exoenzymes degrading polymers can
be useful in optimizing biotechnological processes.
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3General Discussion
3.1 Amino acid side chain combinations restrained to a fraction
of their potential
Our study on combinatorics in AA side chains showed that there is a vast potential from the com-
bination of chemical elements into AAs. Even though we restricted the calculation to aliphatic
side chains without cycles and double bonds, the number of possible AAs grows exponentially
in the number of used carbon atoms118. The question is, why nature uses exactly the present
20 AAs for the assembly of proteins. The ﬁrst intuitive reason is that the combinations must be
tractable, the cells must be able to manage them. The diverse proteins are not only assembled
once in the cells. They are synthesized many times again. Also, a multitude of descendants of
a cell must inherit the trait of utilizing proteins. For these reasons, information of the synthesis
of proteins is stored and not only the proteins themselves. Hence, cells possess machineries to
store, read and write information. How big the protein set of a cell may ever be, it is em-
bedded in an information processing system. One step of this processing is translation of the
information (DNA/RNA) into a functioning, physical representation (proteins). The mapping
is implemented in the genetic code, and could be considered a translation from one symbolic
representation to another one. It is reasonable that this code is small. This is because during
translation the right elementary translation units, the tRNAs, must be chosen again and again.
Though this takes place in aqueous solution wherein molecules can move fast, the bigger the
code is, the more time is needed for a single translation step.
Despite these reasons for a rather small code, still, the questions are, why the number of used
AAs are 20, and why the genetic code has its given structure with the properties redundancy and
robustness, in exactly the implementation as we see it. In principle, a bigger set of AAs, would
allow for higher diversity of proteins, and thus, the exploration of a greater search space from
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which species could have been selected during evolution. In such a larger space, potentially more
and better solutions for ﬁtness optimization could be constructed, which could have evolutionary
beneﬁts against a less diverse system with fewer variation. An argument against this could be
that even with only 20 AAs, variety is big enough to construct any needed protein function.
Moreover, ﬁnding optimal solutions in a larger search space would take more time. Thus, the
bottleneck of protein evolution is perhaps not the amount of variety from combinations, but
rather the time needed to explore it during many generations.
The ﬁrst signiﬁcant restriction of the genetic code comes from having codons with three positions
using four diﬀerent symbols each123,124. This limits the code to have at most 64 translational
units, and hence, at most 64 building blocks for proteins and stop codons.
A simple reason for the current partition of the 64 codons was given in a study showing that
19 or 20 is the most probable number of partitions when having 0 to 3 stop codons. Assuming
that an early code had random variations, this lead to the most probable number of 20 AAs125.
In 1968, Crick126 coined the notion “frozen accident” shortly after the discovery that three
bases code for one AA in 196146, and the deciphering of the genetic code in 196547. It is an
attempt to explain the unusual partitioning of the code. According to Crick, the genetic code
is evolutionary old. Once it was used by higher level mechanisms, as translation, it could not
be changed because minute alterations would have had a huge impact on macro-structures, and
likely be lethal126. This is why the code is relatively universal in nature and only two extensions
are known so far, which are the incorporation of selenocysteine and pyrrolysine by the repurpose
of stop codons127. Crick’s theory poses too few constraints on the code’s evolution in order to
explain its exact organization and the properties of error-tolerance and redundancy128.
Newer research gives evidence that the code’s structure did not arise randomly (by “accident”),
but that the current code’s properties were favored by three forces: diversity, error-tolerance
and cost129. I have discussed the need for diversity already. The more diverse AAs there are, the
more unusual niches of the ﬁtness landscape can be explored, which entails a ﬁtness advantage.
Indeed, there seems to be a selection for the use of versatile AAs130. The other two forces make
the code evolve to have a rather small set of AAs. According to the rate-distortion model, whose
basis is borrowed from information theory131, translation is considered a transfer of a message
(RNA sequence) via a noisy channel (tRNA), which models the misreading of triplets132. It
was argued that the current code structure is a topological feature of this noisy information
transmission process129. Other error sources are replication and transcription. The question
is how to make a code in a way that the message has the highest chance to stay the same or
very similar after translational misreading, and when also mistakes during transcription happen.
First, the code degeneracy is built in a way that codons of a given AA are very similar, i.e.,
they diﬀer in only one, and rarely in two positions. Thus, it is more likely that the translation
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is the same when one position is misread or mutated. Misreadings happen more often in the
ﬁrst codon position. Accordingly, the code had evolved in a way that AAs diﬀering in the ﬁrst
position of their codon are more similar128. Transitions, i.e., conversions from pyrimidine (Y)
to Y and purine (R) to R , happen more often than transversions (Y to R, or R to Y). The code
has evolved in a way that all AAs with a Y or R in the second position are similar to AAs of the
same group. Thus, the chance of having a similar AA after a mutation at the second position is
maximized, and hence there is a smaller negative eﬀect. This property also groups the codons
into encoding hydrophobic and hydrophilic AAs128. Not only is the number of 20 AAs the most
likely one in random partitions (see above125), simulations showed that the number is stable
in a certain range of mutational and selective parameters, even if taken errors in translation
and replication into account. This range is called encoding plateau. These simulations also
showed that the exact partition of codons are determined when taking the errors into account
and having a model of code and message co-evolution128.
Except for glycine and the AAs with six codons, the production pathways of AAs are the same for
codons with the same initial letter133,134,135. In the beginning there was likely a simple genetic
code that was suﬃcient to grasp the few extant AAs, some of which may have originated by
abiogenesis, as supposed by experiments of Miller and Urey136. Accordingly, less discriminative
codes based on triplets were proposed, e.g., RRY137, RNY138,139, and G-nonG-N140 (N stands for
any AA). The code developed gradually to a more information rich one133, which was paralleled
by gradual sharing of codons as AA synthetic pathways developed135. Interestingly, the simplest
AAs from the “primordial soup”136 are encoded as GNN. With the assimilation of the bigger
AAs into the code141, the last codon position became more reﬁned, and e.g., glutamate and
aspartate could be discriminated133. The third mentioned force during the evolution of the
genetic code are the costs to store, replicate, and correct damage of the stored information.
These are further necessities that favored the evolution of a simple code with few AAs129.
In “thawing” of the “frozen accident” theory142, it is clear that the code is indeed very rigid
(“frozen”). It has not changed for millions of years, probably because of its high optimization and
the many macro-level processes depending on it. However, all the mentioned, markedly involved,
properties of the code make an assignment of codons to AAs by chance (“accident”) unlikely133.
Although, there is great potential in a protein “construction kit” with more aliphatic and other
AAs with special chemical properties, the given reasons make a further expansion unlikely. Thus,
we only see a small subset of the vast possibilities of protein building blocks.
One outcome of our study was that despite their combinatorial potential, AA side chains with
more carbon atoms are rarely used. In fact, the largest proteinogenic aliphatic AAs have only
four carbon atoms (leucine, isoleucine), or ﬁve in case of a less strict deﬁnition (lysine). One
argument for this is that bigger AAs would render proteins more cumbersome, and thus, less
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able to execute their function. Another reason are higher costs in production, both in terms
of energy and production time143. A third reason against use of large aliphatic AAs is their
decreased solubility in aqueous solution. Their hydrophobicity would make them well-suited
as inner protein parts, but harder to manage in processes as the production and transport in
cytosol. The last reason we have nearly neglected so far is steric instability. Multiple branching
pushes side chains closer together. More highly branched molecules experience higher strain on
their bonds, which render them thermodynamically more unstable. From a certain complexity
on, compounds will spontaneously fragment144. Even if this reaction is endothermic, entropic
movements will push molecules above this hurdle. C16, the nearly fully saturated, and thus,
branched alkane made of 16 C atoms, is the smallest structure that can not be made due to
thermodynamical instability144. Note, C17 is the according fully branched alkane. It was found
that disallowed structures outnumber allowed ones, already when only excluding C16 and C17
substructures. Still, the number grows exponentially in the number of incorporated C atoms144.
Interestingly, a randomly constructed alkane of above 53kDa (the average yeast protein mass8)
likely does not exist for its high chance of thermodynamical instability. This puts a ﬁrm upper
bound on possible AA structures. It was argued, that there are further thermodynamically
disallowed structures in practice. “Molecular crowding” can take place with less branching, i.e.,
even in molecules without C16 and C17 sub-structures144.
The rigorous restrictions on the ﬁrst level of protein combinatorics, where elements are assembled
into only few used AAs, do not hold for non-proteinogenic AAs. These are not bound to be
incorporated into a ﬁrm code, and thus, their diversity is much higher. Non-proteinogenic
AAs are found in all species and comprise signal transducers, secondary metabolites, fungal
toxins and many more compounds of yet unknown function45,145,146. The majority of those AAs
are unknown to researchers and new ones are discovered consistently, as e.g. AAs contained
in non-ribosomally synthesized peptides in fungi of the Trichoderma genus147. Though their
synthetic pathway and the pathway of incorporation into macro-molecular structures needs
additional genes, energetic and temporal costs are not that much of a factor as for proteinogenic
AAs. Non-proteinogenic AAs can have longer synthetic pathways and reach greater molecular
mass, because they rather take speciﬁc functions and are thus not as abundantly present as
proteinogenic AAs. One example from our publication is 2-amino-9,13-dimethyl-heptadecanoic
acid from Streptomyces sp. 1010 (CO2−C18H36−NH3+, mol. mass 313g/mol, Trp mol. mass
204g/mol)45. However, the restrictions on branching complexity144 and solubility also hold for
non-proteinogenic AA.
2-amino butanoic acid, also known as α-aminobutyric acid (ABU), is an AA that is not incor-
porated into the genetic code, despite its simplicity. We argued that this is for the low gain of
diversity, which means the number of isomeric variants (one) per synthetically “invested” car-
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bon atoms (four) (Fig. 4 in Gru¨tzmann et al.118). To recapitulate, one driving force during the
origin of the genetic code was diversity129. ABU is physico-chemically very similar to the other
small AAs alanine and valine, which are already in the code. Therefore, it was likely disfavored
as a proteinogenic “building block”. However, it was suggested that ABU or similar small AAs
(norvaline, norleucine, and ornithine) were present in an earlier version of the code133. The other
AAs may have also been selected against because of their similarity. Nevertheless, for its low
absolute synthetic costs and ﬂexibility, ABU is used apart from incorporation into proteins43.
3.2 Alternative splicing in fungi
The idea of this project was to extend the research of AS to the fungal kingdom. Fungi are
eukaryotes and have genes harboring introns, which have to be spliced out from the mRNA
during gene expression. Opposed to the other not so well investigated eukaryotic domains,
Chromista and Protista, many fungi are multi-cellular, and have sophisticated lifestyles102,
which necessitate a diverse gene inventory. As in animals and plants, one could expect further
variation of the genetic information via AS. Indeed, many instances of AS associated fungal
genes have been discovered in the last decade81,148,149,150. To our knowledge, there are only few
systematic studies of AS capacities in the fungal kingdom78,79. Also, the question of how AS may
contribute to complexity of the fungal lifestyle and cellular structures has not been approached
yet in a more global multi-species study. As new transcriptome and genome sequences are
uploaded to public databases on a regular basis151,152, a bioinformatics analysis of those allows
for further clearance of the relevance of fungal AS.
In the beginning of our study, only few NGS transcriptome data sets were available for fungi.
In principle, NGS data is preferable for its high sampling depth, good accuracy and low cost.
However, a special requirement of our study was also the availability of a well assembled and well
annotated genome. This narrowed the selection of data sets, and excluded most NGS studies.
Thus, we preferred to base our study on one kind of sequencing technology, with respect to the
transcriptome, namely, Sanger sequencing (classical ESTs) and added one species (Arthroderma
benhamiae) with NGS data for testing.
Our study shows that analysis of NGS reads of greater length (here, A. benhamiae, Roche 454,
average length 297 bases) is feasible with the same workﬂow. We indeed ﬁnd more AS events
for this species, which illustrates a higher sensitivity due to the higher sampling depth. Thus,
we reason that our method is ready to be applied to NGS data. However, due to diﬀerent
properties, results from short-read NGS data might well have a bias compared to results from
classical ESTs. Conclusions on species comparisons would be refutable. To my knowledge,
no one has tried to use both, classical ESTs and short-read NGS in a meta-comparison of
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transcriptomes. Furthermore, the wealth of reads from technologies as RNA-Seq should be
mapped against the genome sequence using faster methods as, e.g. TopHat153. Now-a-days
transcriptome sets consist of several millions of reads154,155 as opposed to ca. one million reads
of our test data set. This also makes parallelization of some of the other analysis steps by
exploiting common multi-core/CPU architectures reasonable.
In our ﬁrst study118 we already found interesting results, which show that it is worth analyzing
fungal AS and its signiﬁcance in more depth. The rate of AS is a ﬁrst obvious proxy for
understanding its signiﬁcance for a species. A central issue was how to estimate AS rates in
a way that they are comparable between species. The attempt in this study was to normalize
the rates for the number of sampled introns, that is, dividing the number of AS events of a
species by the number of introns detected by ESTs. In view of the wide range of data amounts
as well as varying detection and ﬁltering approaches know to the research community, it is
questionable whether all so far found AS capacities are representative and comparable. An
extreme example are the rates of 53% in mouse, and 24% in rat of one study73. For the close
evolutionary relation of both species, their strong divergence in reported AS rates are probably
an artifact. The abundance and distribution of available transcript samples of a species have to
be considered. In cases in which few transcript data are available and cover only small fractions
of genes, AS capacities are typically underestimated, whereas vigorous sampling of transcripts
enables the detection of rare splicing events that may be consequence of stochastic noise of the
splicing machinery. Fox-Walsh and Hertel argued that every multi-exon gene is alternatively
spliced with a certain frequency156. Thus, the detection of an alternative isoform is only a
matter of sensitivity of the method applied, and considering all detectable isoforms can lead to
an over-appreciation of a species’ AS capacity.
Hence, in our second study on fungal AS120, we use the normalization strategy of randomly
sampling ESTs to estimate AS rates. Also, we extended the analysis, investigated more features
and put them into the greater context of multi-cellular complexity. Random sampling produced
AS rates that were independent of the transcript amounts, and are thus more comparable. We
found that the AS rates increased with sampling more ESTs per locus (supplemental Figure S2
in Gru¨tzmann et al. 2013120), presumably because AS events with rarer isoforms were found.
Rates quickly reached a plateau, since most species had a low coverage (EST density), and no
additional events were found. Note, sampling depth of 10 meant to sample at most 10 ESTs,
and still accounting for loci with lower depths. We found that, except for the species with
higher EST coverages, the ratios between the AS rates of the species remain nearly the same
at diﬀerent sampling depths. That is, the curves progress with proportional distance. Hence,
it seems that if sampling depth is in or below the order of all species’ EST coverages, the AS
rates are highly comparable. Furthermore, for species with higher EST coverage (Neurospora
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crassa and Arthroderma benhamiae), AS rates kept rising with higher random sampling depths,
although their ESTs were from diﬀerent platforms (Sanger sequencing, and Roche 454). Thus,
it seems that sequencing technology does not have such a great impact as do read amounts.
This holds as long as EST lengths are clearly above exon and intron sizes, so that AS events
can be detected unambiguously, as was the case here.
An interesting question is, how far the estimates are away from the real AS capacities. This
question also falls back to how frequent a minor splice isoform may occur, that is, the one whose
expression is in general lower than that of the so-called major isoform. At a sampling depth
of 100 reads per SS, feasible with NGS data, the minor isoform can be present as rarely as in
1% of the cases. It is hard to give a universal lower boundary for a meaningful frequency. How
meaningful a boundary is, should also be evaluated with a statistical test. In principle, one
mRNA molecule could be enough for translation into several porteins, because most eukaryotic
mRNAs have half-lives of several hours8. Further, for some processes the presence of a few
proteins is enough to have an eﬀect in a cell. This is, because enzymes, for example, are re-used
for multiple reactions and their half-lives reach over several orders of magnitute36. However,
it is douptious whether a function can be reliably executed when having only a single or few
molecules of an mRNA isoform. This is, because small ﬂuctuations could switch oﬀ the function
completely.
Moreover, it is important to distinguish between functional and spurious or so-called noisy
splicing in order to characterize AS capacities. It is estimated that the raw error rate of the
spliceosome is in the magnitude of 10−4 156. Another error source for AS could be transcription.
Fox-Walsh and Hertel state that ”It is expected that 1 of every 25,000 exons transcribed contains
a single splice-site mutation that induces alternative splicing”156. This could lead to false positive
detected AS events, especially for genes with multiple introns and high EST coverage. Though
further steps in an analysis could sort out these events later, it is reasonable to disregard very
rare isoforms in ﬁrst place. In our study, this is achieved by the random sampling step. At a
maximal sampling depth of 10, only 10 ESTs from one locus are regarded and assessed for AS.
This yields AS events with RNA isoforms of not rarer than 10% after repeating the random
selection for 20 times and averaging the observations in terms of found AS events. Though a
minor isoform expression cutoﬀ of 10% seems very strict, this number was also chosen because
of the low EST coverage in our data, which made deeper sampling unreasonable.
A great part of the fungal AS events are RIs. There are speciﬁc error sources that lead to detec-
tion of false positive RIs. An mRNA isoform with a RI could mean that the intron was not spliced
out but retained by accident. Note, for all other AS types, all isoforms were produced by the
spliceosome and the AS event could not be the result of absent spliceosomal processing. Another
error source of false positive RIs can be the contamination with not yet processed pre-mRNA.
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With current methods in molecular biology it is diﬃcult to extract only cytosolic mRNA. Hence,
EST libraries are made from whole cell mRNA extracts, which could in principle contain unpro-
cessed mRNA from the nucleus (Karol Szafranski, personal communication, December 2012).
However, a poly(A) tail capture was made for most of the used libraries. Thus, the detected
mRNAs were completely transcribed because polyadenylation is the last step in transcription.
Then, because intron splicing occurs predominantly co-transcriptionally53, it had likely taken
place in these RNAs also. Further, it was found that several spliceosomes can assemble onto one
mRNA54, both of which means that splicing can occur concurrently and, in principle, be ﬁnished
fast. This reduces the chance of having false positive IRs due to unprocessed pre-mRNA.
Besides all these hypotheses, we tested the RI-supporting ESTs for evidence of splicing in a
similar manner as it was done in another study157. For nearly all IR events of our study, there
was at least one EST supportive of the RI isoform, that was spliced at another position, that is,
it harbored another processed intron elsewhere. Thus, it is no pre-mRNA that we observe, and
the spliceosome could have spliced the intron that was actually retained. Still, in these cases,
IR could have happened accidentally. It is sensible to limit analyses to regulated, functional AS
events. Only in these cases, the cell controls the event and can exploit it for its cellular function.
However, it is hard to proof regulation and function with bioinformatics analysis only. Even if
retention is not regulated, it will have an eﬀect and the cell has to deal with it. Thus, we did
not put further restrictions on the investigated IR cases.
There are other potential roles for mRNA isoforms with RIs that are not encoded into proteins.
We showed that only one third of the IR events preserve the reading frame. Stop codons have a
very high chance to occur in random sequences (e.g. ≈ 50% in a 15 triplet long sequence), and
thus, only few of the observed RI containing mRNA isoforms can code for alternative proteins.
However, they could have an impact on cellular function via coupling of AS with NMD. In
such a scenario, splicing (co-)factors are recruited in dependence on external conditions, such
as signals transduced from outside the cell, and lead to IR. Then, a premature stop codon in
the RI could trigger the NMD pathway, eventually leading to downregulation of this gene’s
expression. We found that, at least for the fungi present in HomoloGene database, most of the
core components of NMD machinery are conserved. Other studies showed already that NMD
could have a functional role in fungi. Most RIs of the yeast Yarrowia lipolytica contain PTCs,
and there is evidence that corresponding transcripts are degraded by NMD92. Evidence for
functional NMD was seen for N. crassa 158.
Transcripts with RIs could also have a function in evolutionary perspective. Species may test
out new alternative gene material and evolve new functions159,160. If an isoform does not harm
the cell, its expression is unlikely inhibited.
With our study we expanded the knowledge of AS capacities in the fungal kingdom. In their
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study, McGuire et al. found varying numbers of AS events in 14 fungi79. The AS event numbers
for species common to our study are roughly the same, while for N. crassa we found many more
AS events (860 vs. 20). Although we found similar “raw” numbers for C. neoformans 79, our
AS rate estimation is much higher than previously expected (ca. 18% vs. 4%78,81). A few
studies of fungal AS appeared that are based on NGS transcriptome data. By trend, more AS
events were found using this technology compared to our study. For instance, 433 AS events
were found for S. pombe by Rhind et al.161, while we discovered three events. 231 events were
found for Fusarium graminearum 162, and we found 42 events in Fusarium oxysporum. Though
the latter two species are not the same, the numbers may still give a rough orientation because
the species are from the same genus. And last, 1375 AS events were found for A. oryzae 80,
while we discovered 89 events.
More signiﬁcant than the mere estimated AS rates is the eﬀect an AS event has on a species’
cellular function, and ultimately, its life. This is out of scope for a sole bioinformatics analysis,
and only can be proven with biological observations. However, further evidence can be found
beforehand by computational means. One hint can be a protein-coding potential of an alternative
isoform163. A further strong evidence for functionality is conservation of an isoform in other
species, reasoning that a beneﬁcial function would be evolutionary conserved. This also holds
for isoforms that are not translated into proteins, because these can have other functions as
argued earlier. Another hint at functionality of an AS event would be a condition dependent
use of isoforms. An isoform that is observed to be exclusively expressed in a certain growth
condition, tissue type, or developmental stage, is likely regulated and has its dedicated function.
An example for a conserved AS event in fungi whose isoforms are translated into proteins with
diﬀerent functions, is the gene SKI7/HBS1. Interestingly, a whole genome duplication in S.
cerevisiae resulted in a loss of this AS event, but both functions were conserved in form of the
two sub-functionalized genes SKI7 and HBS1164.
The question for this thesis is, if there is complexity via combinations in fungi by the means of
AS? One kind of complexity we see in fungi are the diverse types of growth structures, especially
sexual structures. We found a coincidence of higher AS rates with more complex structures of
the diverse investigated fungal taxa. Especially the simple ascomycetous yeasts (P. stipitis, S.
cerevisiae, S. pombe) have lower AS rates than the other fungi. Another coincidence we found is
that pathogenic fungi have a higher AS rate than non-pathogenic fungi. Virulence is a complex
trait because it involves increased abilities to adapt to changing environmental conditions as
during host invasion. For example, the supply with nutrients changes when proceeding through
diverse host tissues, as is the case for e.g. C. albicans or A. fumigatus 165. Additionally, fungi
have to react to the host defense mechanisms for a successful infection166,167. Furthermore, the
dimorphic switch, the change from yeast to hyphal growth or the other way around, can be seen
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as a complex trait as well, though some non-pathogenic fungi, as Yarrowia lipolytica 168, are also
capable to do this.
UmRrm75 gene of Ustilago maydis putatively encoding an RNA binding protein is upregulated
during dimorphic switch to ﬁlamentous growth induced by acid pH. ΔUmRrm75 mutants show
reduced virulence, mating and post-mating ﬁlamentous growth. Interestingly, UmRrm75 has
an alternatively spliced 3’ SS, aﬀecting one of its three RNA recognition domains. Although
nothing is known about the mode of action of the protein for dimorphism, it is tempting to
speculate that the dimorphic switch could be triggered by a switch of the gene’s alternative
isoform expressions. Each isoform could be involved in determining one of the two fungi’s
growth forms. In this respect, the highly pathogenic opportunistic fungus Candida albicans
would be an interesting study object. As a Saccharomycotina it is closely related to the budding
yeast and harbours more, yet few, introns169 than its relative. So far, only few AS events have
been discovered, which are not closely involved in pathogenicity169,170,171. The hypothesis of an
AS-switch for dimorphism could be one of its intricate mechanism for its opportunistic virulence
in contrast to budding yeast.
The coincidences of high AS rates with complexity in multicellularity and behavior lead us to
speculate that AS could contribute to the phenomenon of multi-cellular complexity. To achieve
this, on the one hand, new proteins could be necessary to encode further functions. Which
could be done by elevated gene numbers or by additional protein isoforms encoded by the genes.
On the other hand, higher complexity can be achieved by more intricate regulation of gene
expression, for example, by coupling of AS and NMD as has been speculated already92.
In terms of combinations, AS can be seen as a layer of diversiﬁcation of genetic material between
transcription and translation. In this study, we approached the question to which extent AS
occurs in fungi. We put special emphasis on comparability of the propensities, which allowed
observations of coincidences with functional and cell structural complexity. Overall, the AS
capacities even of the higher fungi (Basidiomycetes) seem to be clearly lower than that of higher
animals. Still, apart from the ascomycetous yeasts, a considerable fraction of the fungi’s genes is
involved in AS, and a combination of diﬀerentially expressed isoforms is possible. The lower AS
capacities also reﬂect in less intricate AS patterns from single genes. Human genes, e.g., often
harbor several alternatively spliced parts, which can be composed to a multitude of diﬀerent
isoforms172. We rarely found this kind of combination in fungi. The majority of AS aﬀected
genes show only one AS event. Thus, there is few combinatorial complexity form AS in the
individual aﬀected fungal genes. We speculate that up to two thirds of fungal IR events could
be coupled to NMD because they introduce frame-shifts. This could be a way to regulate gene
expression. Thus, there could be multiplicity from combinatorial gene expression regulated or
mediated by splicing (co-)factors. However, the coupling of AS and NMD in fungi remains
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to be investigated, and it can hardly be estimated from current knowledge to which extent it
eventually contributes to organismic complexity.
Finally, the lack of a coding potential of many IR events may be a hint on a rather evolutionary
role of fungal AS. It was hypothesized that AS may accelerate evolution of new functions173.
AS could enable a species to test new sequences in alternative isoforms, thereby, leaving the
established function of the original isoform unaﬀected159,174. In this respect, we found that two
of the over-represented Pfam domains in the AS aﬀected genes are fungi-speciﬁc. These may be
hotspots of accelerated evolution.
3.3 Mutually exclusive exons - A interdependent type of com-
binatorial splicing
In contrast to cassette exons and retained introns, MXEs have not been investigated as exten-
sively in genome-wide fashion. They mostly occur either as side results in AS databases175,176, or
in single gene studies177,178. Thus, we decided to investigate the extent, structure and features
of MXEs in human and mouse. In the years during our study, MXEs have received some more
attention with the appreciation of complex splicing patterns in the human transcriptome172,179.
Also, recently, a genome-wide study of MXEs in D. melanogaster was published180.
In the classical deﬁnition of MXE splicing, exactly one exon out of several appears in the mature
mRNA after splicing. In a less strict deﬁnition, also all of the involved exons may be spliced out
in the mature transcript172. The exclusiveness of these exons strongly depends on the considered
number of tissues and/or conditions the analyzed transcripts are extracted from. For example,
the human gene TCL6 shows MXE properties when comparing only few tissues. However, the
pattern is lost when mRNA from all known tissues is considered62. In the end, detection of
a MXE splicing event always depends on ﬁnding a, potentially very rare, condition for which
exclusiveness of the exons is rejected. To approach such an uncertain classiﬁcation, we suggested
that MXEs are categorized as such, as long as the majority of reported transcripts support the
exclusive pattern122. A similar dichotomy is the rare case of a hand with six ﬁngers, which is
still called a hand despite the deviation from the usual case122. After all, the question is, if
the isoforms have a physiological role that can only be executed with the exclusive occurrences,
and if the presence of non exclusive patterns in other tissues and conditions interferes with the
function.
MXE is the only AS type where the resultant protein isoforms can have the same length, when
only considering AS aﬀected translated mRNA regions. This opens the opportunity to exchange
protein parts while maintaining the overall protein structure. Thus, various protein isoforms
can easily be encoded that have the same overall function but diﬀer in speciﬁcity, e.g., an
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RNA binding protein with sequence speciﬁc isoforms. An example are MXEs in chicken beta-
tropomyosins that are alternatively incorporated into smooth or skeletal muscle cell mRNA178.
Another example is a neuronal ion channel, whose activation speed is altered upon exchange
of MXEs177. Also, MXEs in D. melanogaster are enriched in transmembrane transporter and
ion-channel activity180, corroborating the idea that MXEs contribute to speciﬁcity of isoforms.
MXEs are thought to have originated from exon duplication181. For this reason, one expects
MXEs to lie adjacently on the pre-mRNA. Thus, usually, AS analysis pipelines are designed
in a way that only discovers adjacent MXEs. Another reason for the design is probably the
ease of implementation. When allowing more structural exceptions, the implementation is more
diﬃcult, including testing and assuring reliability of the predictions. However, in our analysis
we did not restrict the MXEs to lie in close vicinity. In doing so, we found that most of them
are non-adjacent. That is, there are constitutively spliced exons between them. We found that
non-adjacent MXEs have a higher tendency to cause a frame shift, which makes them more
likely to trigger NMD. We also found that non-adjacent MXEs have a bigger length diﬀerence
and a lower sequence similarity (not published). All this suggests, that they unlikely originate
from exon duplication, and an alternative explanation for their origin should be sought.
Another diﬃculty in implementation is the question of how well-deﬁned the bordering introns
and exons must be. That is, if exact genomic positions of adjacent introns and exons are found
in all transcripts supporting an MXE isoform. The more strictly deﬁned these borders are, the
more reliable are the predicted MXEs. However, implementation of strict borders is diﬃcult
because there is signiﬁcant variation in the exons and introns next to an MXE. This is due to
the high splice variation of the human transcriptome, which often yields multiple AS events for
one gene76,172,179. Adherence to strictly deﬁned MXE borders can lead to exclusion of potential
MXEs, merely, because other AS events happen adjacently. This in turn is a signiﬁcant issue in
terms of number of predicted MXEs and comparability to other studies predicting MXEs. Last
but not least, the length of sequenced ESTs restricts how well-deﬁned the border of an MXE
can be.
We only found MXEs involving two exclusive partners in our study on mouse and human.
This is interesting because in less complex organisms as D. melanogaster the rather involved
MXE patterns with multiple exons were found. However, this does not mean that mammalian
splicing patterns are less complex. The average human gene has 7.8 introns95, and the average
D. melanogaster gene has less than four introns per gene 1. AS patterns in fruit ﬂy should be
less intricate in general than in human. There are between 1841 and 4275 AS aﬀected genes
reported for D. melanogaster in the databases DEDB, FlyBase, ASAP II, ECgenec, which are
13.6 introns per gene, calculated from 13,379 reported genes and 48,039 splice junctions, based on Misra et
al.182
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about 11-30% of all genes175. By contrast, more than 90% of the human genes were found
to be involved in AS75,76, with an estimated 88,000-132,000 AS events, and at least seven AS
events per multiexon gene on average76. Even when considering these results optained from
NGS data as overestimation, AS was found to aﬀect more than half of the human genes in
previous studies74,183. On top of that, both, the absolute number and the proportion of complex
AS events (others than IR, CE, A3’SS and A5’SS) are generally higher in vertebrates than in
invertebrates62. Finally, we found cluster spliced MXEs in human, which are complex forms of
MXEs, in which a group of exons is spliced in mutually exclusive manner to another exon or
exon group. On top of that, most of these cluster spliced MXEs are non-adjacent, all of which
allows for a complex restructuring of coding material.
Opposed to other basic AS types, the way MXE splicing is implemented by the cell is not ob-
vious, and has not been elucidated to full extent. Several regulatory mechanisms have been
proposed, some of which were already proven to be utilized in diﬀerent species. These are
spliceosome incompatibility184, steric hindrance185,186, coordinated splicing control coupled to
NMD187, and last, a whole class of regulatory mechanisms in which RNA secondary structure
elements are involved in exon choice. The latter ones are docker selector pairing188,189, induced
steric hindrance190, and forming of a splicing activation complex directed by RNA pairing and
recruitment of cis-control elements189. Most of the proposed regulatory mechanisms are inap-
propriate for non-adjacent MXEs. The reasons are given already in our review122.
Only the mechanism of forming a splicing activation complex led by cis-control elements, is
feasible for non-adjacent MXEs, as long as no further details are discovered that may pose
restrictions on close exons and introns. Further mechanisms for non-adjacent MXE splicing reg-
ulation are conceivable that make use of regulatory microRNAs and epigenetic factors involving
chromatin restructuring65. Likely, as in adjacent MXE splicing, there are diﬀerent modes of
action, which are used in diﬀerent species. However, as non-adjacent and clustered MXEs are
an only recently appreciated AS type, substantial research on their regulation still has to be
undertaken.
It becomes clear that it is not enough to only consider the basic established AS types to un-
derstand the meaning of AS of higher eukaryotes. For instance, considering the exons of an
MXE event separately, they appear to be skipped exons. One could wrongly conclude that
a part of the putatively resultant protein is excised and a certain function is switched oﬀ, or
a spliced-out localization sequence yields the transport of the protein to another place in the
cell. However, only when appreciating the whole MXE event, it is clear that the protein part
is actually exchanged with another one. Now this is a completely new property that can not
be realized by two ordinarily skipped exons. Moreover, it is possible that the disallowed iso-
forms of some MXEs are deleterious. Likewise, one can imagine emergence of new functions by
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other dependent or even more complex AS patterns. While considering only local patterns and
analyzing the basic AS types allows for a rough scan of the AS capacities, only the analysis of
their combinations, if there are any, enables the proper understanding of the involved biological
phenomena. Therefore, the goal must be to delineate the complete AS patterns of all genes as
well as their conditions and locations of expression. As mentioned earlier, some scientists speak
of an AS code, with reference to the notion genetic code. It is a set of rules that determines
the outcome of AS on transcript level191,192. Clearly, the code can not be a direct translation
of symbols as in case of the genetic code. First, the current knowledge points at such a code to
consist of many components that act in cumulative manner, meaning the outcome is determined
by the sum (or diﬀerence) of their inﬂuence65. Second, there will be code components that are
rather soft determiners of the AS outcome. Examples are the concentration of trans-factors,
or the similarity of found sequences to known cis-splicing motifs. This also can necessitate the
modelling of probabilities rather than ﬁxed rules, because the mere presence of a factor in the
cell is no guarantee that it is eﬀective, e.g. by binding. And third, AS is tightly involved in
other processes of gene expression, for example transcription67,68. Thus, an AS code can not be
a simple mapping, or the application of a few simple rules. In sum, I propose to use the notion
“code” only with caution. One step of success was the tissue speciﬁc prediction of exon inclu-
sions with high accuracy involving around 200 features derived from transcript sequences193.
While the actual regulatory relation is hidden and only indirectly represented in the algorith-
mic predictor, feature maps can be generated that can guide mechanistic studies193. Still, an
immense investigative task remains: the incorporation of further tissue types, the inﬂuence of
external and internal stimuli and conditions, and especially, the prediction of more involved AS
patterns into such an algorithm.
An interesting question is, if dependencies as in MXE splicing could be predicted by more so-
phisticated computer programs. Simply, if the dependencies are caused by or correlated with
features that are learned by or in other ways implemented in the algorithm, such a prediction
is feasible. Probably, as extension of the study of Barash et al.193, a fully accurate predictor
will involve features of trans-acting splice factors, too. Once, the putatively black box-like pre-
dictor is trained, the most signiﬁcant learned features could be extracted. Using these features,
hypotheses for MXE regulation mechanisms could be generated that are testable in biological
experiments.
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3.4.1 Complexity through combination - a universal principle
The central theme of this thesis is complexity arising from combination. Two areas were in-
vestigated in which this reﬂects: aliphatic AA side chains, and alternative mRNA splicing.
Combination is a universal principle in biology. Many biological systems comprise distinct parts
or building blocks, which are combined to form a whole. One great beneﬁt of this principle is,
that novelties in nature emerge by combination in a fast and inexpensive way. Here, inexpen-
siveness coins, e.g., low metabolic costs and few eﬀort in genetic coding. To corroborate the
hypothesis of the universality of the principle, I will give some examples of implementations in
nature.
Nucleotides are combined in sequential order to code genes in the DNA of chromosomes. Their
order strictly determines the order of AAs, which are combined into proteins8. In case of func-
tional non-coding RNA, ribonucleotides are combined to RNA molecules that form secondary
structures to execute their function194. Spatial structure and physico-chemical properties of pro-
teins and functional RNAs are determined by the order and properties of their building blocks.
Their sequential combination is inﬂuenced by diﬀerent mechanisms taking place on diﬀerent
time scales. One way of combination is the genetic recombination of gene material during meio-
sis. During the process of crossing-over, homologous chromosomes of diﬀerent mating partners
are aligned and DNA sequences are exchanged by the chromosomes, necessitating DNA strand
breaks and ligations8. In another example, on the scale of populations, new nucleotide com-
binations can emerge by horizontal gene transfer. It was shown that, e.g., bacteria and fungi
interchange coding DNA sequences and thus novel gene material can spread in a population of
species195,196. This material is not only tolerated but also used by its new host, in that, for
instance, resistances against antibiotics via special encoded enzymes can quickly propagate in
bacteria197.
Another example on cellular level, cell types can be seen as combinations of organelles. Following
the endosymbiont theory, for instance, mitochondria arose by incorporation of prokaryotes into
the bigger eukaryotic cells million years ago198. Another example of organelles contributing to
cell type identity in chordates are the number of nuclei, which ranges from zero in red blood
cells to several hundreds in muscle cells8.
A relatively new research ﬁeld is the inﬂuence of histone marks on gene expression. Histones can
be post-translationally modiﬁed at diverse AA positions and with several types of modiﬁcations,
for example phosphorylation, methylation, and acetylation16. These marks are not static but
change during a cell’s life and determine expression of a nearby gene in a combinatorial way199.
Interestingly, these modiﬁcations can be inherited and constitute an alternative way of carrying
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over information to a succeeding generation200.
The multitude of immunoglobins, which are needed by B cells of the immune system to defend
against a yet unseen antigen of a new pathogen, are constructed from a small set of antibody
genes by diﬀerent genetic mechanisms. One of them is the V(D)J recombination of the variable
domains of antibodies, during which a random combination of various genomic segments is
selected during B cell maturation in the bone marrow201.
The last example is the conjoint expression of genes in cells. Though (almost) all somatic
cells of a species carry the same genomic blueprint, only distinct expressed combinations of
them determine cell and development type identity in metazoan. On a more abstract level on
which genes encode proteins that take part in metabolic pathways, a cell can also be seen as a
combination of a subset of all possible such pathways. For example, in contrast to skeletal muscle
cells, red blood cells do not produce energy via the Krebs cycle, but rather use the Embden-
Meyerhof pathway36. Another example are amino acid (AA) synthetic pathways. There are
groups of AAs that share the same pathway. While the beginning reactions are the same for
similar AAs, the later parts are branched, and other enzymes complete the AAs synthesis133.
In the following, I will show how combinations underlie the two major topics of my thesis,
alternative splicing and side chains of aliphatic AAs. Thereby, it will become evident that
conceiving the combinatorial structure of these systems is often critical for understanding their
entire nature.
3.4.2 Combinatorial complexity beyond the genetic code
Only few amino acids are used for the assembly of proteins, despite the vast potential from
the combinatorial nature of their side chain structure. Even though we restricted the study to
aliphatic AAs without rings and double bonds the calculation of the combinations gets rather
complicated. AAs with aromatic rings, which appear in natural proteins, could only be con-
sidered if double bonds and rings were allowed. Furthermore, if one wanted to also regard the
proteinogenic AA proline, rings without double bonds and bonds to the AAs’ amine nitrogen
would have to be considered as well. Then, AAs derived from ring shaped azacycloalkanes
could also be regarded. These are another class of AAs with relevance in nature. For example,
azetidine-2-carboxylic acid is a toxin in Liliaceae plants202, and piperidine-2-carboxylic acid
occurs in the lysine metabolism of the murine brain203. However, in this case, one may have to
set a threshold for the allowed size of rings, because such an AA with a three-membered ring is
under strain, very reactive, and thus toxic204. It was not found in living organisms so far204.
In the end, despite a better appreciation of occurrences in nature, these kind of exceptions and
extensions would inﬂate the calculation formula considerably. At some point, calculation would
be too complicated and simulations of the chemical structures would be necessary.
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The main ﬁnding was that the number of theoretical possibilities given the restrictions grows
exponentially. This is the essence of the potential of combinations. A small set of micro-level
rules, yields an inconceivable number of combinations on the macro-level. For the assembly of
proteins, there are two micro-levels involved in combinations. On the ﬁrst one, chemical elements
are combined to molecules, in this case AAs with diverse side chains. On the second level, the
AAs are united to chains by peptide bonds. On both levels, combinations have exponential
potential in terms of their compounds: there are approximately 2.8n aliphatic side chains from
n carbon atoms, given the restrictions of our study, and there are 20m possible proteins of length
m when having a “construction kit” of 20 diﬀerent AAs. Interestingly, nature seems to exploit a
bigger part of the potential for the construction of proteins only on the second level. In principle,
a cell could choose from (2.8n)m possibilities to construct its proteins. However, for the reasons I
gave already above that involve an eﬃcient genetic code (3.1, page 87), there are exactly 20 AAs
with the exact partitioning of the code as we see it. Opposed to this small “construction kit”,
the amount of stored information need not to be ﬁnite or tractable. A cell’s genome comprises
thousands to billions of nucleic acid bases of data harboring genetic information8,205. For these
reasons, on the ﬁrst micro-level of combinatorial protein diversity, only few of the many possible
combinations are realized in form of proteinogenic AAs. However, many more of the possibilities
of the second level of combination are realized: several million of AA sequences have been found
and characterized so far206.
Still, the amount of constructable, meaningful proteins with speciﬁc functions is not nearly
grasped by research. This reﬂects in the task of predicting protein structures from AA sequences
that keeps challenging scientists for decades207. Not less diﬃcult are the reliable prediction of
protein function208,209 and protein interaction210,211, which are particularly diﬃcult in cases
where no homologs of the underlying sequences are available. Despite the great variety and
universality of proteins constructable via the genetic code, nature seems to have the need for
further expansion. This happens on many levels, one of which is the expansion of the genetic
code in form of the encoded AAs selenocysteine (Sel) and pyrrolysine (Pyl)39,40,41. As of the year
2003, there were 25 selenoproteins known in human, most of which have Sel in their enzymatic
active site212. These proteins could probably not execute their function as eﬃciently without
Sel, because selenium makes it more reactive than sulfur in the analogous cysteine213. Similar to
Sel, Pyl is situated in the active site of enzymes, for example in methyltransferases. Its pyrroline
ring is assumed to take a speciﬁc role in catalyzation214. Again, this AA probably contributes
to a more eﬃcient execution of catalytic functions than alternative AAs would do.
Standard codons are re-purposed by the incorporation of speciﬁc RNA secondary structures to
realize the incorporation of Pyl and Sel. Besides encoding further AAs, many other codons
were found to have dual functions. Examples are the utilization of the leucine codon CUG for
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serine in the yeast Candida cylindracea, the read through of stop codons enhanced by cis- and
trans-acting factors, and the coding of the codon UGA for tryptophan instead of a translation
stop in mitochondria of vertebrates42.
Another expansion of the protein variety is realized in form of post-translational modiﬁcations
(PTMs), as e.g. phosphorylation, methylation, glycosylation, hydroxylation, and acetylation16.
Prohaska et al. showed that complexity in chromatin regulation indeed increased in step-wise
fashion during evolution215. With respect to the extent of PTMs, it was found that 16% of the
Swiss-Prot annotated proteins are modiﬁed as observed experimentally, and around 44% are
putatively modiﬁed216. Some types of PTMs add chemical groups that can not be found in pro-
teins right after translation (e.g. phosphate), and thus, result in speciﬁc properties that can not
be encoded in AA sequences directly. Some changes result in addition of small chemical groups
(e.g. alkyl groups). During others, whole proteins or peptides are added (e.g. SUMOylation217).
Again others result in structural changes (e.g. disulﬁde bonds). In sum, PTMs oﬀer a very high
degree of diversiﬁcation of protein structures and functions. Many features introduced by PTMs
are not achievable by direct encoding into AA sequences using the current genetic code.
In respect of these extensive modiﬁcations, the genetic code can be regarded as an “accident”,
i.e. being suboptimal, in the form in which it became nearly “frozen” a long time ago. However,
I hypothesize that the later addition of diversity through PTMs was the optimal solution in the
overall perspective. A ﬁrst small and tractable code was advantageous for the primordial species
of the early history of life. Diversifying expansion in form of, e.g., PTMs is advantageous for the
exploration of and speciﬁcation into niches, presumably not until less relative costs of a species
were spent for mere survival. Setting up a more extended, ﬂexible code ﬁrst would have had a
negative eﬀect on the ﬁtness of the simple early organisms.
PTMs have the further beneﬁt of adding speciﬁcity fast. Some PTMs, as phosphorylation and
acetylation, are only temporal. They are, for example, used for signal transduction8. They have
a switch-like, alternating nature: while kinases add phosphate groups, phosphatases remove
these8. It is rather diﬃcult to encode this functionality into the primary sequence.
The need for diverse “building blocks” can also be seen on the level of nucleic acid sequences.
The four standard nucleotides are suﬃcient for secondary structure formation in single-stranded
nucleic acids. However, the alphabet of tRNA is expanded for several unusual nucleotides
derived by, for example, methylated standard nucleotides36. These allow for interactions with
synthetases and ribosomes by better accessibility or higher hydrophobicity36.
3.4.3 Combinatorial complexity in alternative splicing
In general, AS is understood to be a major contributor of the complex phenotype of higher
eukaryotes. This is by encoding protein isoforms with distinct cellular destinations, switching
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oﬀ binding capacities of transcription factors, altering enzyme catalytic sites and many more
diﬀerent properties65. AS can be seen as the recombination of parts of pre-mRNA. An AS event
gives rise to at least two mRNA isoforms that can distinguish in as few as one nucleotide, up to
as many as several hundred nucleotides. Complexity arises by combination, especially when an
mRNA is aﬀected by multiple AS events. On average, a human gene has nearly eight introns95.
More than 90% of all human genes are aﬀected by AS, and there are at least seven AS events
per multi-exon gene on average76. An example for the huge combinatorial potential of AS are
the neurexin genes with more than 2000 putative isoforms218. And again, the extreme example
in D. melanogaster is the DSCAM gene. It contains four clusters of 12, 48, 33 and 2 exons. Out
of each cluster, one exon is selected in a mutually exclusive way, respectively. If the selection
happens independently, 12 · 48 · 33 · 2 = 38, 016 isoforms could be produced from this gene63.
A further diversiﬁcation by AS is achieved by diﬀerential expression of isoforms from diﬀerent
genes that act together to have an outcome. The combinatorial eﬀect of splice isoforms can
be seen during chaperone synthesis during proteotoxic stress response. The synthesis is mainly
regulated by the transcription factors (TFs) Heat Shock Factor 1 and 2 (HSF1, HSF2), which
have two alternative isoforms. It was found that the HSF2β isoform inhibits HSF1β activity and
that the isoform expression ratio of both factors determines the cellular level of stress response
in a quantitative way219.
On a more systemic level, AS contributes to organ development and disease. For example, the
heart consists of several tissues and cell types with speciﬁc functions that allow to execute the
central role of this organ in a concerted way. AS crucially adds diversity to the transcriptome that
is needed for the complex structures and functions of a heart. For example, cardiac troponin T,
and Ca2+/calmodulin-dependent protein kinase mRNAs are alternatively spliced. In addition,
many SR proteins, hnRNP proteins and other splicing trans-factors were found to regulate heart
development220.
In the beginning of AS research, AS may have only been appreciated as a process to add protein
isoforms with a slightly diﬀerent function or, which even may have been doubted to have any
biological relevance. With nowadays perspective, many cellular processes can only be fully
understood when taking the role of AS into account. Another intriguing example next to the
above mentioned heat shock factor genes, is a tri-geminal ganglion-speciﬁc splice isoform of a
cation channel in vampire bats. It enables the bats to sense warm-blooded animals in contrast
to fruit-feeding bats whose orthologous receptor gene does not produce the necessary isoform221.
Some AS events do not only inﬂuence a single function of a terminal protein with a restricted
involvement, but aﬀect many downstream processes or even play a central regulatory role as
controlling transcriptional networks in animal development222. An example is a switching AS
event speciﬁc to embryonic stem cells that changes the DNA binding aﬃnity of the FOXP1
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TF. This in turn, induces the expression of central TFs of pluripotency and inhibits expression
of genes for diﬀerentiation223. In another example, AS aﬀects many conserved protein-coding
regions during the transition from mitotic to meiotic growth of murine sperm cells. Moreover,
many key regulators of splicing were diﬀerentially regulated224. AS may signiﬁcantly aﬀect
global transcriptome expression, and contribute to the fundamental change to meiotic growth.
Splicing is often involved in such complex phenomena as diseases. It is estimated that more
than one third of single nucleotide polymorphisms causing diseases aﬀect splicing225. These
eﬀects are mainly mediated via disruption of core and cis-splicing elements225. An alteration
in splicing can not only cause a single form of a disease, but AS can contribute to diversity of
complex diseases as, e.g., prostate cancer. This impairs standardization of therapies and makes
individualized treatment necessary226. Furthermore, also diﬀerent mutations of splicing factors
can yield subtypes of diseases, as was shown in a recent study on myelodysplastic syndrome227.
3.4.4 Costs of the combinatorial principle
Undoubtedly, there is a vast potential behind creating biological complexity through combina-
tions. The main beneﬁt is that new things as macromolecular structures or biological functions
can be created from using already existing parts. However, there are signiﬁcant costs involved.
Often there has to be a kind of machinery that assembles, recombines or interprets the combina-
tions. Examples are the spliceosome with its several 100 compounds50, the molecules involved
in setting and reading histone marks, and the enzymes responsible for V(D)J recombination
of antibodies201. Those combination-managing systems require to be produced and assembled
themselves, as well as be modiﬁed and transported to their right cell locations. This all involves
costs in terms of time and energy, the latter one often in form of ATP. For AS, further costs
involve the degradation of the excised introns (lariat)36, and the buildup and management of
the compounds involved in NMD, if this pathway is used. The mutual dependencies of the
investigated MXEs necessitate additional controlling factors as proteins, which go not without
expenses. As discussed earlier, large AA side chains have a higher potential in structural di-
versity. The downside here is that large side chains also involve higher costs in production in
terms of energy consumption and time needed before they can be used143. Signiﬁcant costs are
involved in the implementation of the genetic code. Transfer RNA have to be synthesized as well
as their corresponding aminoacyl synthetases, which connect anticodons with AAs. Similar to
the spliceosome, yet not that large, is the ribosome - a ribonucleoprotein whose heterogeneous
subunits have to be produced and assembled. Eventually, all the information has to be stored
in a huge genome, consisting of nucleic acids and histones, all of which have to be produced too.
DNA has to be replicated, restructured and DNA damage must be repaired. This consumes
large amounts of energy36.
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Another downside of managing combinatorial complexity is the evolutionary time needed to
evolve such machineries. In short term perspective, there is an advantage to encode and build
complex structures directly. For example, having a gene expression regulator that binds the
DNA and inhibits a speciﬁc gene’s transcription seems more practicable than adding splice
regulators and a whole NMD machinery for the downregulation, as introduced earlier. However,
once a combination-managing apparatus is developed, it can be used universally with slight
modiﬁcations. As examples, the NMD pathway is used for many genes91, and the recombination
system is built for many meiotic divisions to come36. Then, the gained evolutionary beneﬁt
probably made up for the put about eﬀort during evolution. In the light of the universality
of the combinatorial principle, this conclusion can be drawn for many aspects of biological
complexity.
3.4.5 Restriction of combinations
Another phenomenon of the principle of complexity by combination is the restriction of the huge
combinatorial potential. One inherent restriction lies in the fact that the time is not suﬃcient
to test every of the often exponentially increasing number of possibilities. One example is
that the immune system usually needs some hours up to days to ﬁnd a matching antibody to
an antigen201. Here, ﬁnding an appropriate combination fast, decides about nothing short of
the mere survival of the whole organism. In another example, there are 20361 ≈ 4.7 · 10469
possible eukaryotic proteins when calculating with the median protein length of 361 AAs228.
Many of those are far from having a structural relevance (e.g. 361 times alanine). However,
even with a heuristic search and only testing of, at ﬁrst glance not meaningless proteins, likely,
only a marginal fraction has ever been tested by nature. Thus, there is space for evolutionary
improvement even if we froze the current environmental conditions so that species only had
to optimally adapt to a static surrounding. A practical reason for restriction is that novelties
remain controllable. If for instance, new proteins were tested at high throughput and in parallel,
the chance of having harmful outcomes with uncontrollable eﬀects for a species would be high.
From an evolutionary perspective, populations would have a high risk of extinction. This also
reﬂects in the example of extending the set of proteogenic AAs by ones with new side chains.
Indeed, an evolutionary very slow expansion took place. Only selenocysteine and pyrrolysine
have been discovered so far39,40,41. The reason is, that the genetic code is a very central system
on which many cell processes depend in a fundamental way. For both new AAs, the reuse of
existing stop codons via additional signals, the secis229 and pylis230 RNA structure elements,
was likely the easiest way of incorporation. A reprogramming of parts of the genetic code, that
is, the re-assignment of anticodons to diﬀerent AAs, would certainly have had great negative
impact on the aﬀected species, or would have taken a very long time for evolution.
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For these reasons, the exploration of the combinatorial potential often takes place in a piece by
piece fashion, whereupon only few novelties are tested at a time. This is, for instance achieved,
by very low mutation rates of species genomes231,232. Though meiotic recombinations yield
huge numbers of new combinations, the exchanged parts (alleles) are very similar, both in mere
sequence and actual function. There are combinations that show clearly altered phenotypic
outcomes, for example, for aging233 and disease234. However, new allele combinations have no
frequent, dramatically diﬀerent outcomes - a claim that is underlined by billions of successful
recombinations during mankind’s history. With evolutionary selection, combinations that lead
to detrimental results usually have a lower ﬁtness resulting in lower chance to maintain in a
population. Thus, the eﬀect with respect to populations is even smaller. An example for piece
by piece exploration in AS is, that cassette exons that arose newly from exonization of Alu
elements have low inclusion rates. That is, the expression of the isoform harboring the new exon
is lower than that of the original isoform52. This way, a potential malicious eﬀect of the minor
isoform can be held down more easily.
A piece by piece discovery of combinations is unreasonable for the vast amount of recombinations
that need to be screened during antibody construction. The immune system has developed
special mechanisms to avoid deleterious eﬀects resultant from recognition of antigens of the own
body. Lymphocytes are tested for the reactivity to these self antigens during maturation, and
undergo apoptosis if such a reaction is found201.
MXEs harbor an interesting type of restriction. An MXE of two exons could be regarded as
two cassette exons for which two of the possible splice combinations are inhibited: the exclusion
and inclusion of both exons. While at ﬁrst glance, this restricts the potential of combinations,
it implements a speciﬁc function, as explained earlier (section 3.3, page 97). Such a function is
not easily achievable without the avoidance of certain splice combinations in MXEs.
Summarizing, through the various types of restrictions of combinations, species are able to better
control the vast potential of combinatorial complexity. This enables them to keep the chance for
deleterious eﬀects low, and to develop and implement new cellular functions at the same time.
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